Loyola University Chicago

Loyola eCommons
Master's Theses

Theses and Dissertations

1997

Saccharomyces Cerevisiae-Produced Recombinant Pfs230: A
Malaria Transmission-Blocking Vaccine Candidate
Kathryn M. Glynn
Loyola University Chicago

Follow this and additional works at: https://ecommons.luc.edu/luc_theses
Part of the Biology Commons

Recommended Citation
Glynn, Kathryn M., "Saccharomyces Cerevisiae-Produced Recombinant Pfs230: A Malaria TransmissionBlocking Vaccine Candidate" (1997). Master's Theses. 4270.
https://ecommons.luc.edu/luc_theses/4270

This Thesis is brought to you for free and open access by the Theses and Dissertations at Loyola eCommons. It
has been accepted for inclusion in Master's Theses by an authorized administrator of Loyola eCommons. For more
information, please contact ecommons@luc.edu.
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License.
Copyright © 1997 Kathryn M. Glynn

LOYOLA UNIVERSITY CHICAGO

Saccharomyces cerevisiae-PRODUCED RECOMBINANT Pfs230:
A MALARIA TRANSMISSION-BLOCKING VACCINE CANDIDATE

A THESIS SUBMITTED TO
THEFACULTYOFTHEGRADUATESCHOOL
IN CANDIDACY FOR THE DEGREE OF
MASTER OF SCIENCE

DEPARTMENT OF BIOLOGY

BY
KATHRYNM.GLYNN

CHICAGO, ILLINOIS
MAY, 1997

Copyright by Kathryn M. Glynn, 1997
All rights reserved.

ii

ACKNOWLEDGMENTS

I would like to thank Dr. Kim Williamson for being an enthusiastic advisor, a
thorough instructor, and also a friend.

I am truly grateful for her patience and

encouragement. Thank you also to my committee members, Dr. John Smarrelli and Dr.
William Wasserman for their invaluable insight and flexibility with respect to this project.
I would also like to thank Dr. Martin Berg for his statistical advice and Mr. Joseph
Schluep, Dr. Bryan Pickett and his wife Paula for their help with prints and slides. A
special thanks to Aaron, Anita, and Drew who made going to lab everyday a more
enjoyable experience. To the many undergraduates who have worked in Kim's lab, and to
all of the graduate students, thanks. I really appreciate all of your support and your
humor. Finally, to my parents, thanks for everything.

iii

for my family,
especially LCDG

TABLE OF CONTENTS

ACKNOWLEDGMENTS

iii

LIST OF ILLUSTRATIONS

vii

LIST OF ABBREVIATIONS

viii

Chapter
I.

INTRODUCTION

1

Purpose
......................................................................
Literature Review
. . . . . . . . . . . . . . . . . . .. . .. . .. . . . . . . . . . . . . . . . . . .. . . . . . .. . . . . . . .
II.

MATERIALS AND METHODS
Experimental Design .......................................................
Reagents
.. . . . . . . . . .. . . . . . . . . . . .. . . . ... .. ... . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . .
Transformation of E.coli with YEp Plasmid ............................
YEp Plasmid Preparation (Minipreps) ...................................
Restriction Endonuclease Digestion of YEp Plasmid .. ...... .. ....... ..
YEp Plasmid Modification . . . . .. ........ .. . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . .
Construction of Pfs230.C-Nterm Expression Vector ..................
Manual DNA Sequencing .. ..... .... ..... ......... ........ ..... .... ..... ...
Transformation of S. cerevisiae with C-Nterm/mYEp Construct .....
Inducing Protein Expression in S. cerevisiae
Transform an ts
....... .................. ......... ...... .. ...... .......
Trichloroacetic Acid (TCA) Precipitation and SDS-PAGE ............
Ni2+-NTA Purification of Recombinant C-Nterm Protein .............
Western Blot Analysis of Ni2+-NTA Purified Protein ..................
Glycoprotein Detection Assay . . . . . . . . ............. ....... ......... ... . . .. .
C-Nterm Protein Sequencing ..............................................
Yeast Spheroplast Preparation/DNA Extraction .... .............. .......
Transformation of E.coli with yC-Nterm/mYEp Construct
Recovered from S. cerevisiae . .. . .. . .. . .. . .. .. . . . . .. . .. . .. . .. . .. . ..
Automated DNA Sequencing yC-Nterm/mYEp Construct .............

III.

RESULTS

1
2
18
18
19
19
21
21
22
26
30
32
33
33
34
35
36
37
38
39
40
41

Vector Modification .........................................................
Pfs230 Expression Vector . . . . . . . .. . .... ...................................
Manual DNA Sequencing .. ..... .... ......... ..... .... .... ..... .... ........
S. Cerevisiae Transformation ....... ........ ......... ... ...................
Western Blot Analysis of Proteins in Yeast Supernatant .... ... .... ....
Ni2+-NTA Purification of Recombinant C-Nterm Protein ..............

v

41
46
49
52
54
55

Characterization of Purified C-Nterm .....................................
C-Nterm Protein Sequencing ..............................................
C-Nterm/DNA Sequencing ................................................
Automated DNA Sequencing ..............................................

57
63
63
68

IV.

DISCUSSION

72

V.

CONCLUSION

86

REFERENCES

88

VITA

92

vi

LIST OF ILLUSTRATIONS

Page

Figure
1.

Schematic of Pfs230

2.

Kpn I Digest of YEp Vector

3.

Annealed Oligonucleotide YEpH611

...... ...... .. .. . ... . . . ... . .. . .. . . .. .. . .. ..

43

4.

Size Fractionation of YEp and mYEp Nhe I Digests ........................

45

5.

Size Fractionation of PCR Amplified Pfs230.C-Nterm ....................

47

6.

Schematic Representing the mYEp Vector . ... . . ...... ..... ... .. ... ... .......

48

7.

Kpn I and Spe I Digests of mYEp and C-Nterm/mYEp

50

8.

Comparison of Reported Sequence of Pfs230 and
Manual Sequencing Data .. .. . . .. . .. . . .. ... ... . . .. . . . . . .. . . ... .. . . . . . .. . . . ..

51

TCA Precipitated Supernatant of Yeast Transfected
with C-Nterm/mYEp
.......................................................

53

Ni2+-NTA Purification of Protein from C-Nterm/mYEp
Transfected Yeast
. . .. . .. . . .. . .. . .. . .. . .. . .. . .. . . .. . .. . . . . .. . . . . .. . . . . . .. . .. .

56

Coomassie Staining and lmmunoblot Analyses of
Purified and Unpurified Proteins .........................................

60

Electrophoretic Analysis of Purified C-Nterm on a
15% SDS-Polyacrylamide Gel ............................................

62

Glycoprotein Analysis of C-Nterm/mYEp Transfected
Yeast Supernatant
...........................................................

64

14.

Amino Acid Sequence of Pfs230.C-Nterm

..................................

65

15.

Restriction Digests of yC-Nterm/mYEp and C-Nterm/mYEp ..............

67

16.

Sequencing Pfs230.C-Nterm

69

9.

10.
11.
12.
13.

13

vii

.. .. . .. .. .. .. ... .. .. . . .. . .. . .... .. . . ... . . . . .. .. . .. ..

42

LIST OF ABBREVIATIONS

ADH

alcohol dehydrogenase promoter

BCIP

5-bromo-4-chloro-3-indolylphosphate
p-toludine salt

CFU

colony forming units

dd

distilled/deionized

ddNTP

dideoxyribonucleoside triphosphate

DIG

digoxigenin

DTI

dithiothreitol

EDTA

ethylenediaminetetraacetic acid

EtOH

ethanol

FCA

Freund' s complete adjuvant

HEPES

4-(-2-hydroxylethyl)-1piperazineethanesulfonic acid

HPLC

high performance liquid chromatography

LB

luria broth

MBP

maltose binding protein

MCS

multiple cloning site

MeOH

methanol

mYEp

modified Yeast N-Terminal FLAG
expression vector

NBT

nitroblue tetrazodium
nickel nitrilo-tri-acetic acid

00

optical density

viii

PAGE

polyacrylamide gel electrophoresis

PBS

phosphate buffered saline

PCR

polymerase chain reaction

pl

isolelectric point

PNK

polynucleotide kinase

sos

sodium dodecyl sulfate

SCM

synthetic complete medium

SRP

signal recognition particle

TAE

Tris-acetate/EDTA

TBS

Tris-buffered saline

TBE

Tris-borate/EDTA

1CA

tricholoroacetic acid

1E

Tris/EDTA

TRP

tryptophan

YEp

Yeast N-Terminal expression vector

YPD

basic yeast growth media

YPHSM

YP4 high stability expression media

ix

CHAPTER I
INTRODUCTION

Purpose

In an effort to control the morbidity and mortality associated with human malaria,

transmission-blocking vaccines have been given careful consideration as a means of
halting the spread of the disease (Mendis et al., 1990).

The main objective of a

transmission-blocking vaccine is to prevent mosquitoes from becoming carriers of the
parasite which causes malaria. Parasites in the form of sporozoites are deposited into the
bloodstream of a human when a mosquito takes a bloodmeal. This is the beginning of a
cycle of infection that proceeds in the human host culminating in the production of both
asexually and sexually reproducing parasites.

When a mosquito takes an infectious

bloodmeal, the parasite undergoes further maturation in the mosquito midgut enabling it to
be transmitted to another human. Parasite maturation and subsequent transmission can be
blocked if antibodies which recognize parasite surface proteins are also present in the
bloodmeal. The focus of this project is on the production of a recombinant protein that can
be tested for its ability to induce malaria transmission-blocking immunity. This target
antigen is Pfs230 which is found on the surface of the sexual stages of Plasmodium
falciparum (P. falciparum), the parasite responsible for causing the most virulent form of

human malaria.
Pfs230 was first identified as a malaria transmission-blocking vaccine candidate by
Rener et al. who found the protein to be the target of monoclonal antibodies that reduce
parasite infectivity in the mosquito midgut (Rener et al., 1983). Recently, six regions of
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Pfs230 were expressed as fusions with maltose-binding protein (MBP) in Escherichia coli
(E. coli) (Williamson et al., 1995).

Antisera against one of those six regions,

r230.MBP.C, which encodes amino acids 443 to 1132 of Pfs230, was found to generate
antibodies that significantly reduce parasite infectivity in the mosquito midgut (between
71.2-89.8%) (Williamson et al., 1995). This region of Pfs230 contains twelve cysteines
(Williamson et al., 1993) that in parasite-produced Pfs230 probably form distinct disulfide
bonds which help define the conformation of the protein. Pfs230-specific monoclonal
antibodies that have transmission-blocking activity only recognize non-reduced parasiteproduced Pfs230 (Quakyi et al., 1987) suggesting that the conformation of the monoclonal
antibody epitopes in the native protein depends on disulfide bonds. Because recombinant
Pfs230 was synthesized in the reduced cytosolic environment of E. coli, proper formation
of these critical disulfide bonds may have been inhibited. This may explain why antisera
against E. coli-produced Pfs230 region C (r230.MBP.C) did not completely block parasite
infectivity.
The purpose of this study was to express and characterize a region of Pfs230 (CNterm) in Saccharomyces cerevisiae (S. cerevisiae). A yeast expression system has been
previously shown to accurately recreate the conformation in another P. falciparum protein,
Pfs25 (Kaslow and Shiloach, 1994). C-Nterm (amino acid 447 to amino acid 584 of
Pfs230) encodes the amino terminus of Pfs230 region C which may the include the region
of Pfs230 that is processed as the parasite emerges from the red blood cell. Additionally,
C-Nterm is a small enough region of Pfs230.C to be expressed efficiently in a yeast
expression system.

Literature Review

It is estimated that almost one half of the world's population is threatened by

malaria (Saul, 1992; WHO, 1993). Present in over 100 countries, the disease, caused by
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mosquito-borne parasites, is responsible for 300-500 million clinical cases annually
(WHO, 1993). Approximately one to three million people die each year from malaria
related illnesses and most of those are children (Hoffman and Miller, 1996).

Malaiia

continues to be a serious problem in the tropics because measures devised to control it,
such as the use of anti-malarial drugs, larvicides, and insecticides have proven insufficient
in eliminating the parasite and preventing its transmission to the mosquitoes (Hoffman and
Miller, 1996).
Human malaria is caused by four species of protozoan parasites of the genus
Plasnwdium: P. falciparum, P. vivax, P. ovale, P. malariae (Oaks, 1991). Although P.
vivax is responsible for causing the most infections worldwide, the most virulent of those

parasites is P. falciparum (van Dijck et al., 1995).

The parasites are transmitted to

humans by a sub-group of 50-60 species of mosquitoes in the genus Anopheles (Oaks,
1991).
Malarial parasites were first seen in humans in 1880 (Review by Markell, 1992).
Their development both in the anopheline mosquito and in the human bloodstream had
been understood and the life cycle elucidated by the early 20th century (Review by
Markell, 1992). Upon being bitten by an infected anopheline mosquito, the parasite is
introduced into humans in the form of sporozoites (Oaks, 1991). Within forty minutes
following injection into the human host sporozoites invade hepatocytes (Markell, 1992).
During the following five to fifteen days the sporozoites develop into schizonts within the
liver cells (Oaks, 1991). Each of these schizonts goes on to develop into 10,000 to
30,000 merozoites (Oaks, 1991). After rupturing the infected hepatocytes, merozoites are
released into the bloodstream where they are able to invade erythrocytes. Once in the
erythrocyte merozoites begin to asexually reproduce. Within 48-72 hours each merozoite
matures into a schizont containing eight to thirty-two new merozoites (Oaks, 1991).
Eventually the infected red blood cells rupture releasing merozoites which are then free to
infect other erythrocytes (Oaks, 1991).

Rupturing of these red blood cells releases
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parasite metabolites which are toxic and may contribute to the symptoms associated with
malaria, such as fever (Markell, 1992).
Some time after asexual parasites first appear in the bloodstream a subpopulation
of merozoites differentiates into either male or female gametocytes. This form of the
parasite grows within red blood cells but does not divide and matures to become the
infectious form of the parasite. The trigger for the differentiation between the asexual and
sexual life cycle is unknown (Markell, 1992). When an anopheline mosquito draws blood
from an infected individual, red blood cells containing parasites (including gametocytes),
as well as other serum components such as antibodies and complement, are taken up by
the insect. The sexual stage of parasite development then proceeds in the midgut of the
mosquito.
Under the influence of a change in temperature and/or chemical environment,
intraerythrocytic gametocytes taken up in a bloodmeal emerge from the red blood cells in
the mosquito midgut minutes after ingestion (Carter, 1988a). Presumably due to some
substance released by the gametocytes themselves, the host red blood cell membranes are
disrupted and gametocytes become extracellular (Carter, 1988a). Shortly after emergence,
male gametocytes differentiate into eight highly motile microgametes, a process known as
exflagellation (Carter, 1988a).

These microgametes then proceed to fertilize female

gametes derived from corresponding gametocytes (Carter, 1988a).

Fertilization is

complete less than 30 minutes after the parasite is ingested by the mosquito (Carter,
1988a). From the point of red blood cell emergence onward the parasite is extracellular
and is therefore exposed to host components present in the bloodmeal such as
complement, cytokines, and antibodies (Carter, 1988a).
In the 12-48 hours following fertilization, a zygote transforms into an ookinete

which penetrates the mosquito midgut wall to become an oocyst (Oaks, 1991).

The

oocyst continues to develop on the serosal surface of the midgut adjacent to the haemocoel
(Carter, 1988a). This oocyst enlarges over time forming greater than 10,000 sporozoites.
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After the oocyst ruptures, sporozoites are released and migrate to the salivary glands of the
insect where they are ready to infect the next human, thus perpetuating the cycle of
infection (Oaks, 1991).
Because alternative measures to control or eradicate malaria have met with only
limited success, the past two decades have focused on the development of antimalarial
vaccines in attempt to control the disease worldwide. There are four major categories of
vaccines classified according to the part of the parasite life cycle that they are designed to
attack: 1) Pre-erythrocytic vaccines are aimed at preventing sporozoite invasion of liver
cells and/or destroying parasite infectivity of hepatocytes; 2) Blood stage vaccines try to
limit replication of erythrocytic stage parasites;

3) Anti-disease vaccines attempt to

alleviate anemia, fevers, and other clinical illnesses associated with malaria;

4)

Transmission-blocking vaccines are designed to prevent infected individuals from
transmitting the parasite back to the mosquito thus halting the spread of the disease
(Kaslow, 1993). Transmission-blocking vaccines, aimed at the sexual stage of parasite
development, target either intraerythrocytic gametocytes in the vertebrate host or
extracellular gametes that emerge in the insect (Kaslow, 1993). This type of vaccine will
not necessarily protect already-infected individuals, but it may reduce the spread of malaria
by slowing or halting the transmission of the parasite from the vector to the host (Oaks,
1991). Most likely, transmission-blocking vaccines would be administered in conjunction
with pre-erythrocytic and blood stage vaccines in attempt to combat malaria related
illnesses (Oaks, 1991). A combination vaccine targeting more than one stage of parasite
development would likely make it more difficult for the escape parasites to mutate in an
attempt to evade immune responses.
The earliest demonstration of transmission-blocking activity was in 1958 when
Huff et al. immuniz.ed chickens with the avian parasite P. gallinaceum and noted that host
factors (possibly antibodies) could decrease the relative infectiousness of gametocytes
(Huff et al., 1958). Chickens were immunized with P. gallinaceum-infected, formalin
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treated erythrocytes and two to three days later challenged with an infective inoculation of
live gametocytes (Huff et al.. 1958). Experiments revealed that when mosquitoes took a
bloodmeal from these immunized chickens there was a significant decrease in the ability of
gametocytes to produce oocysts in the mosquito midgut (Huff et al., 1958). This evidence
of transmission-blocking immunity was further supported in 1976 when Gwadz
immunized chickens with an inactivated preparation of P. gallinaceum-infected red blood
cells (Gwadz, 1976).

Immunized chickens were infected and then Aedes aegypti

mosquitoes were allowed to take a bloodmeal. P. gallinaceum infectivity in the mosquito
was measured by counting the number of oocysts per midgut (Gwadz, 1976).

In

mosquitoes that ingested gametocytes from twice (or more) inoculated chickens infectivity
was reduced 95-98% (Gwadz, 1976). It was noted however that by immunizing chickens
there was little effect on asexual parasitemia and that immunization did not affect
gametocyte production in the host (Gwadz, 1976). In follow-up studies, Carter and Chen
used partially purified gametes to immunize chickens and found infectivity was further
reduced to 99.9-100% (Carter and Chen, 1976; Carter et al., 1979).

Again, asexual

parasitemias in experimental animals correlated with the asexual parasitemias found in the
controls (Carter and Chen, 1976; Carter et al., 1979). The study by Carter and Chen
further noted that immunizations with partially purified preparations of both male and
female gametes were more effective in reducing parasite infectivity to the mosquito than
were single sex gamete preparations (Carter and Chen, 1976).
While studies had shown that immunizing chickens with gametes resulted in a
decrease in oocyst development in the mosquito (Gwadz, 1976; Carter and Chen, 1976;
Carter et al., 1979) those same studies failed to indicate that any protection was being
offered against the asexual stages of parasite infection. Subsequent studies with monkey
and rodent malarias did show transmission-blocking immunity as well as protection
against the asexual parasites (Gwadz and Green, 1978; Mendis and Targett, 1979). In a
study by Gwadz and Green, rhesus monkeys were immunized with an antigen preparation
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of asexual and sexual stage P. knowlesi parasites emulsified in Freund's Complete
Adjuvant (FCA) (Gwadz and Green, 1978). After challenge with P. knowlesi, monkeys
immunized with the antigen preparation and FCA were not infectious to feeding
mosquitoes (Gwadz and Green, 1978). The authors of this study hypothesized that antigamete antib~dies produced in the monkeys could have been responsible for blocking the
sexual development of P. knowlesi in the mosquito (Gwadz and Green, 1978). This was
illustrated by the fact that antisera from immunized monkeys showed complete
transmission-blocking activity and had microgamete immobilizing activity (Gwadz and
Green, 1978). Neither activity was evident in the controls (Gwadz and Green, 1978). In
addition, immunized monkeys seemed to be protected against asexual parasites and had
significantly reduced parasitemias and consequent pathology (Gwadz and Green, 1978).

It was purported that suppression of asexual parasitemias could have been due to the
asexual parasites used in the antigen preparation or due to antigens common to both
asexual and sexual stages of the parasite (Gwadz and Green, 1978). In a similar study,
Mendis and Targett showed that mice vaccinated with a crude preparation of P. yoelliforrnalin fixed gametes showed significantly reduced infectivity to mosquitoes and well as
a pronounced (though not complete) immunity to the erythrocyte stage parasites (Mendis
and Targett, 1979). Their study also showed that an effective block on transmission was
possible without the use of an adjuvant.
The first study to demonstrate a correlation between transmission-blocking
immunity and anti-gamete antibodies in immune serum was performed by Gwadz et al.
(Gwadz et al., 1979).

For this study chickens and monkeys were used as the

experimental models. Animals were immunized with preparations containing gametes of
their respective malaria parasites, P. gallinaceum and P. knowlesi (Gwadz et al., 1979).
Mosquito feeds and subsequent mosquito midgut oocyst counts showed that transmissionblocking immunity was induced in the animals (Gwadz et al., 1979). In addition, it was
shown that when parasitized blood from an immunized chicken or monkey was washed
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free of its plasma and then resuspended in non-immunized serum the gametocytes
recovered full infectivity to mosquitoes (Gwadz et al., 1979).

Furthermore, when

parasitized blood from non-immunized chickens was fed to mosquitoes in the presence of
serum from immunized birds, infectivity to mosquitoes was completely suppressed
(Gwadz et al., 1979).

These results suggest that it is some serum component (i.e.

antibodies) that mediates transmission-blocking immunity. Agglutination reactions and
fluorescent antibody tests did indicate anti-gamete antibodies were present in the chicken
and monkey serum (Gwadz et al., 1979).

The presence of anti-gamete antibodies

suggests that reduction in parasite infectivity was mediated by anti-gamete antibodies
which were ingested in the mosquito bloodmeal (Gwadz et al., 1979). These antibodies
have been shown to interact with extracellular gametes as they emerge from the red blood
cells thereby preventing fertilization in the mosquito midgut (Gwadz et al., 1979).
In transmission-blocking immunity, similar to vaccines against the asexual stage of

parasite development, surface proteins are targeted. Most transmission-blocking research
has focused on antigens present on the surface of parasites during the extracellular, sexual
stage of development:
1991).

namely, proteins on gametes, zygotes, and ookinetes (Oaks,

Three vaccine candidates that appear on the surface of gametes have been

identified: Pfs230, Pfs48/45, and Pfs40/10. In addition, Pfs25, which is expressed at the
late gamete/early zygote stage of development, and Pfs28, present on the ookinete surface,
have also been identified.
The focus of this research project was on Pfs230. Rener et al. were the first to
indicate that Pfs230 was one of the target antigens for transmission-blocking immunity
(Rener et al., 1983). The Rener et al. study showed that two monoclonal antibodies
(monoclonal antibody IA3-B8 and monoclonal antibody IIC5-B10) acted synergistically to
target the surface of P. falciparum strain 708 (a Brazilian isolate) (Rener et al., 1983).
Together, but in the absence of complement, these two monoclonal antibodies mediated
almost total suppression of infectivity to mosquitoes (Rener et al., 1983). In addition,
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monoclonal antibody IA3-B8 alone, in the presence of activated complement, suppressed
infectivity to mosquitoes by 90% (Rener et al., 1983). In the absence of complement
either monoclonal antibody had slight effect in reducing infectivity, suggesting that the
effects of monoclonal antibody IA3-B8 alone were complement mediated (Rener et al.,
1983).
In contrast to the studies by Rener et al., a later study tested the ability of several

monoclonal antibodies to block malaria transmission and found that only one of fifteen
monoclonals developed, monoclonal antibody 28Fl, was monospecific for Pfs230
(Vermeulen et al., 1985). Yet monoclonal antibody 28Fl failed to exhibit transmissionblocking immunity (Vermeulen et al., 1985). Three other monoclonal antibodies which
precipitated Pfs230, monoclonal antibody 29F432, monoclonal antibody 7F3, monoclonal
antibody 32Fl and also antibody 1771 (rabbit polyclonal antibodies), always did so in
conjuction with Pfs48/45 (Vermeulen et al., 1985). The fact that Pfs230 and Pfs48/45
coprecipitated might suggest that these proteins are interrelated and possibly possess a
common antigenic site (Vermeulen et al., 1985). Alternative possibilities may be that
Pfs230 and Pfs48/45 interact by coprecipitating nonspecifically or that they form a
complex on the surface of the parasite.

The monoclonal antibodies that coprecipitate

Pfs230 (monoclonal antibody 29F432, monoclonal antibody 7F3 and monoclonal
antibody 32Fl) always bound significantly more Pfs48/45 (Vermeulen et al., 1985).
Additionally, a positive reaction to Pfs230 could never be detected with monoclonal
antibody 29F432, monoclonal antibody 7F3, monoclonal antibody 32Fl, or rabbit
polyclonal antibodies (Vermeulen et al., 1985). This may lend support to the theory that
Pfs230 coprecipitates with Pfs48/45 nonspecifically or forms a complex with Pfs48/45.
The Vermeulen et al. study further showed that monoclonal antibody 32F3 and
monoclonal antibody 32F5, which specifically precipitate Pfs48/45, most effectively
blocked oocyst formation in the mosquito. The authors therefore concluded that Pfs48/45
was a good transmission-blocking vaccine candidate. The authors further suggested that
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Pfs230 merely coprecipitated with Pfs48/45 and probably was not a transmission-blocking
vaccine candidate antigen (Vermeulen et al., 1985).
A study by Quakyi et al. however reestablished Pfs230 as a transmission-blqcking
vaccine candidate showing that it alone was the target of two transmission-blocking
monoclonal antibodies, 1B3 and 2B4 (Quakyi et al., 1987).

Pfs230 was also

immunoprecipitated by monoclonal antibody IIC5-B10, rabbit serum raised against whole
gametes, and rabbit serum raised against purified Pfs230 (Quakyi et al., 1987). In the
presence of complement, monoclonal antibody 1B3 and monoclonal antibody 2B4
suppressed infectivity of P. falciparum 3D7 (an Amsterdam isolate) to mosquitoes by 95100% (Quakyi et al., 1987). Neither monoclonal antibody suppressed infectivity when
complement was heat inactivated, suggesting that monoclonal antibody 1B3 and
monoclonal antibody 2B4 were complement dependent (Quakyi et al., 1987). In addition,
monoclonal antibody 1B3 and monoclonal antibody 2B4 only reacted with Pfs230 under
reducing conditions suggesting that the conformation of the epitopes recognized by
monoclonal antibodies were defined by disulfide bonds (Quakyi et al., 1987). A followup study reported that the epitopes defined by monoclonal antibody 1B3 and monoclonal
antibody 2B4 were generally well conserved among 45 isolates examined by
immunofluorescence assay (Foo et al., 1991). This relative absence of antigenic diversity
of Pfs230 among different strains of P. falciparum is promising for transmission-blocking
vaccine development as the vaccine would probably be effective against most isolates.
Field studies have indicated that Pfs230 is a good transmission-blocking vaccine
candidate and is naturally immunogenic (Graves et al., 1988; Carter et al., 1988b;
Premawansa et al., 1994; Riley et al., 1994). Trials done in Papua New Guinea evaluated
serum from adults living in this malaria endemic area and found that antibodies against
Pfs230 correlated with the ability of the serum to block malaria transmission (Graves et
al., 1988). Individuals in the study had all been exposed to multiple reinfections (Graves
et al., 1988). Naturally occurring antibodies to Pfs48/45 were found in the Papua New
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Guinea sera but they did not directly correlate with a decrease in parasite infectivity of the
mosquito midgut (Graves et al., 1988). In contrast to the Graves et al. study. a recent
study in Sri Lanka, an area of lower malaria transmission, has shown that followipg an
acute primary infection, antibodies against Pfs230 did not correlate with anti-parasite
activity (Premawansa et al., 1994). Considering the results of both studies it is possible
that perhaps only repeated challenges with malarial infection lead to a maturation of
transmission-blocking immune response (Premawansa et al., 1994).
In addition to the aforementioned studies Read et al. have identified sixteen

monoclonal antibodies which specifically recognize Pfs230 under non-reducing conditions
and define nine distinct epitopes of the protein (Read et al., 1994). These same sixteen
monoclonal antibodies failed to react with Pfs230 when the antigens were treated with
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mercaptoethanol, suggesting that Pfs230 monoclonal antibodies were conformation
dependent (Read et al., 1994). This evidence of reduction sensitive antibodies upheld a
previous study by Quakyi et al. Eight of the monoclonal antibodies in Read's study of the
IgG 2a isotype mediated complement dependent lysis of gametes (Read et al., 1994).
Seven other monoclonal antibodies of murine immunoglobulin isotype IgG 1 (which do not
fix complement) failed to lyse gametes. This suggested, as Quakyi et al. did before, that
anti-Pfs230 antibodies are complement dependent (Quakyi et al., 1987; Read et al., 1994).
Because Pfs230 can elicit an immune response during a natural infection, it may be
that an immune response to a subunit vaccine could be boosted during a natural infection
in humans (Hoffman and Miller, 1996). This maybe important for inducing long lasting
immunity. This could also give a Pfs230 vaccine an advantage over other transmissionblocking candidate antigens (i.e. Pfs25) which do not elicit immune responses upon
natural infection (Kaslow, 1993).
Pfs230 was cloned and sequenced from both the 3D7 (derived from NF54
Amsterdam Airport isolate) and the 7G8 (derived from a Brazilian isolate) P. falciparum
strains (Williamson et al., 1993). The gene encodes a 363 kDa protein. There are a
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number of distinct physical properties associated with the protein.

Pfs230 has three

regions of highly net negative charge across the protein which includes the 25 contiguous
glutamine (E) residues and sixteen tandem E-E/G-V/E-G repeats located at the amino
terminus of the molecule (Figure 1). The charged regions of the surface protein are
speculated to act as a shield for the parasite by protecting it with an electrostatic field
thereby preventing aggregation by repulsion (Williamson et al., 1993). The remainder of
the molecule contains seven cysteine motifs which are presumably involved in the tertiary
structure of Pfs230 (Figure 1) (Williamson et al., 1993; Carter et al., 1995).
Pfs230 is present on gametocytes prior to gamete development in the mosquito
midgut and is therefore present in the human host (Kumar and Carter, 1984). It was
found that Pfs230 protein expression is localized to the parasite plasma membrane in both
gametocytes and gametes (Williamson et al., 1996). The protein is synthesized on day
two of gametocytogenesis (Vermeulen et al., 1986). Recently it was demonstrated that the
360 kDa form of the molecule is processed to a smaller, 310 kDa protein at a time which
corresponds to gamete emergence from the red blood cells (Williamson et al., 1996).
The physical properties of Pfs230 may be linked to immune evasion strategies by
the parasite (Williamson et al., 1996). Recall that in humans Pfs230 is expressed by
intraerythrocytic gametocytes as a 360 kDa protein containing numerous E-E/G-V/E-G
repeats (Figure 1).

It is often the case that repeat regions such as these are

immunodominant because many copies of the same sequence often increase the avidity for
antibodies (Kemp et al., 1987). Although circulating parasites are hidden in host red
blood cells there is evidence that a host immune response can be generated to Pfs230 upon
a natural infection (Graves et al., 1988; Carter et al., 1988b). This is probably due to
parasitized red blood cells that are cleared by the spleen and then presented to the immune
system (Carter, 1988a; Carter, 1988b). Because much of the antibody response generated
in malaria infections is directed toward repeat epitopes (Kemp et al., 1987), an immune
response would probably be directed towards the repeat epitopes in the amino terminal 50
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Figure 1. Schematic of Pfs230. The unique physical properties of Pfs230 include the
stretch of glutamates and the E-E/G-V/E-G repeats near the amino terminus of the full
length 360 kDa protein. In addition, the molecule contains seven cysteine motifs which
are likely involved in the tertiary structure of the protein.
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kDa of Pfs230, the region which is shed upon parasite emergence from the red blood cell.
If the first 50 kDa were targeted by host antibodies, these antibodies would be present in a

bloodmeal and the parasite would become exposed to the antibodies in the mosquito
midgut. By shedding the amino terminal 50 kDa of the protein, parasites evade an
immune response and cannot be recognized by antibodies directed towards the repeat
region (Williamson et al., 1995). This strategy-of-evasion theory is supported by studies
that suggest that the most immunoreactive regions of recombinant Pfs230 proteins are
amino acids which encode the (E-E/G-E/V-G)n repeats within the first 50 kDa of Pfs230
(Riley et al., 1995).
A recent study reported the production of six recombinant Pfs230 proteins which
were produced in E. coli as fusions with MBP (Williamson et al., 1995).

These

recombinants, which encoded 83% of Pfs230, were labeled r230.MBP.A-r230.MBP.F.
The immunogenicity of these recombinants was tested in mice (Williamson et al., 1995).
One region, r230.MBP.C (Figure 1), induced antibodies that significantly reduced parasite
infectivity (71.2-89.8%) in the mosquito midgut (Williamson et al., 1995). r230.MBP.C
encodes amino acid 443 to amino acid 1132 of Pfs230. This is the region immediately
following the E-E/G-E/V-G repeats and includes the first cysteine motif.

The initial

recombinants were produced in the reduced cytosolic environment of E. coli, not the
secretory pathway of a eukaryote, and thus disulfide bonds may have formed randomly
during the preparation or purification of Pfs230 region C as an antigen. If Pfs230 region
C was expressed in heterogeneous conformations in E. coli, crucial epitopes within that
region may or may not have been formed as they are in parasite-produced Pfs230. This
would result in some antisera that recognizes parasite-produced Pfs230 and some that does
not. Accordingly, only a subpopulation of the antibodies produced may effectively block
transmission. Thus to further evaluate the ability of region C to induce transmissionblocking immunity it is necessary to express this region in other systems such as yeast or
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mammalian cells which target the recombinants to a secretory pathway and permit correct
disulfide bond formation.
The objective of this project was to express region C-Ntenn of Pfs230 (amino acid
447 to amino acid 584) in yeast. This portion of the molecule is important for two
reasons. C-Nterm is a small part of Pfs230 region C, a region which has been previously
shown to generate antibodies that reduce P. falciparum transmission to mosquitoes. In
addition, C-Nterm is a small enough region to be expressed efficiently in yeast. The yeast
expressed C-Nterm protein could later be tested for its ability to induce antibodies that
decrease parasite infectivity in the mosquito midgut. If yeast expressed C-Nterm is a more
potent immunogen than E. coli-produced r230.MBP.C, vaccine efforts may be focused on
yeast produced C-Nterm. Furthermore, future experiments could be done with C-Nterm
protein to determine if it encodes the precise region where stage-specific processing of
Pfs230 occurs. This may lead to further insight into parasite immune evasion strategies.
S. cerevisiae, or baker's yeast, has been the first choice of many investigators to
supplement prokaryotes in the production of recombinant proteins. The major reasons a
yeast expression system was chosen for this project is because it offers high protein yield
as well as the possibility of inexpensively scaling up production of protein for a vaccine.
In addition, yeast have been shown to produce other recombinant P. falciparum proteins,

such as Pfs25 and MSAl, in high yield (Kaslow and Shiloach, 1994; Hui et al., 1994).
Also, the extensive secretory pathway yeast proteins undergo will likely yield a more
properly conformed protein than E.coli did (Gellissen, 1992). This may be of particular
importance for a Pfs230 vaccine since it has been shown that transmission-blocking
monoclonal antibodies which recognize the molecule are conformation dependent (Quakyi
et al., 1987; Read et al., 1994).

The secretory pathway in eukaryotes has been firmly established. Polypeptides
with hydrophobic amino terminal regions, like the a signal sequence in S. cerevisiae, can
be targeted for secretion through the rough endoplasmic reticulum (Alberts et al., 1994).
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The signal sequence targets the protein for production/translation in the rough endoplasmic
reticulum by binding to the signal-recognition particle (SRP) complex (Alberts et al..
1994). One end of the SRP complex binds to the signal sequence while the other end
binds to the ribosome (Alberts et al., 1994). This step causes a temporary pause in
translation to prevent the protein from being released into the cytosol (Alberts et al.,
1994). Once formed, the SRP ribosome complex then binds to the SRP receptor in the
rough endoplasmic reticulum membrane and translation continues (Alberts et al., 1994).
The polypeptide is then translocated across the rough endoplasmic reticulum where the
signal sequence is cleaved by a membrane bound protease (Tuite and Oliver, 1991). Once
in the rough endoplasmic reticulum, resident chaperones and isomerases may bind to the
nascent polypeptide chain and regulate folding, disulfide bond formation, and
posttranslational modification. After translation, the protein is delivered to the Golgi for
further processing and then the protein can be shuttled via secretory vesicles to the
extracellular space.
Posttranslational modification of yeast proteins begins in the rough endoplasmic
reticulum. While N-linked glycosylation, a frequent form of posttranslational modification
in yeast, is initiated in the rough endoplasmic reticulum, the extension of oligosaccharide
side chains occurs in the Golgi apparatus. Fully glycosylated proteins are then transported
to the plasma membrane and the contents are discharged (Tuite and Oliver, 1991).
Glycosylation can occur in one of two ways: N-linked glycosylation occurs at asparagine
residues in the sequence asn-X-ser/thr where Xis any amino acid except proline; 0-linked
glycosylation occurs at serine or threonine residues. While C-Nterm lacks the requisite
sequence for N-linked glycosylation, there are thirteen serines and seven threonines in
Pfs230.C-Nterm, leaving C-Nterm sensitive to 0-linked glycosylation. In yeast, 0-linked
glycosylation exclusively involves the addition of mannoses directly to serines or
threonines usually in chains of 5 or less (Tanner and Lehle, 1987).
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Another posttranslational modification carried out by yeast which can alter protein
structure includes phosphorylation, which involves the addition of phosphates to the
hydroxyl groups of serine, threonine or tyrosine residues (Alberts et al., 1994).
Sulfation, also a posttranslational modification, occurs primarily at tyrosine residues in
secretory proteins (Han and Martinage, 1992).

In addition to the many serines and

threonines in C-Nterm, this region of Pfs230 also contains eight tyrosines. One other type
of posttranslational modification is fatty acylation (the addition of hydrophobic acid groups
to proteins). Isoprenylation is the addition of a 15 carbon fatty acid (farnesylation) or 20
carbon fatty acid (geranylgeranylation) to the carboxy terminus of proteins (Caldwell et
al., 1995). Palmitoylation is also a type of fatty acylation which involves the addition of a

16 carbon chain to cysteine residues throughout the length of polypeptides.
Myristoylation, which occurs cotranslationally, is the attachment of a 14 carbon chain to
the amino terminus of a protein (Schafer and Rine, 1992). Most reports have these fatty
acid additions occurring in the cytosol (Alberts et al., 1994) and are therefore unlikely to
appear on a yeast secreted recombinant protein.

CHAPTER II
MATERIALS AND METHODS

Experimental Design

A previous study showed that antisera to an E. coli-produced recombinant of
Pfs230, r230.MBP.C (encoding amino acid 443 to amino acid 1132), decreased parasite
infectivity in the mosquito midgut by 71.2-89.8% (Williamson et al., 1995 ). This project
concentrated on generating S. cerevisiae-produced recombinant Pfs230 which can be used
in future studies to test for its ability to induce complete malaria transmission-blocking
immunity. To do this, mice will be vaccinated with yeast produced Pfs230.C-Nterm. The
antisera generated will then be used to test for decreased parasite infectivity in the
mosquito midgut.
The expression vector used in this study was the Yeast N-Terminal Flag
Expression Vector (YEp) (Eastman Kodak Company, New Haven, CT). YEp is a 7205
base pair plasmid with a multiple cloning site (MCS) region. An fl origin of replication
allows this vector to replicate in E. coli and a selectable marker is provided by the
ampicillin resistance gene. A two micron circle element and a tryptophan (TRP) selectable
marker are encoded in the vector for growth and selection in yeast.

The vector was

modified to encode a six histidine tag at the 3' end of the multiple cloning site to provide a
means of purifying the recombinant protein. To express the amino terminus of Pfs230
region C (amino acid 447 to amino acid 584) the nucleotide sequence was amplified via the
polymerase chain reaction (PCR). The resultant PCR product and the modified yeast
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expression vector (mYEp) were digested with compatible restriction endonucleases and
ligated together. E.coli was transfected with this plasmid construct (C-Ntenn/mYEp) via
electroporation. Transfected bacterial colonies were grown on solid media, selected,
amplified in liquid media, harvested, and the construct recovered. The isolated plasmid
construct was transfected into yeast, S. cerevisiae. Yeast colonies that grew in the absence
of tryptophan (TRP) were selected and then grown in a medium conducive to protein
expression. After the protein was expressed it was purified and characterized to determine
if it was recombinant Pfs230.C-Nterm.

Reagents

Unless otherwise indicated, chemicals were purchased from Sigma Chemical
Company, St. Louis, MO and restriction endonucleases and DNA-modifying enzymes
were purchased from Life Technologies, Gaithersburg, MD.

Transformation of E. coli with YEp Plasmid

Luria-Bertani (LB) medium [l % (w/v) Bacto-tryptone (Difeo Laboratories,
Detroit, Ml); 0.5% (w/v) Bacto-yeast extract (Difeo Laboratories, Detroit, Ml); 1% (w/v)
NaCl (Brown, 1991)] was inoculated with JM109 E. coli cells from a glycerol stock
(Promega Corporation, Madison, WI) and then incubated at 37°C, 250 rpm (Lab-Line
Instruments, Melrose Park, IL) for 48 hours. A 300 µl aliquot of the saturated culture
was added to 50 ml fresh LB and grown at 35.5°C, 240 rpm to an OD600 of 0.58.
The cells were harvested (2420 x g, five minutes, 4°C) and the supernatant was
quickly decanted. The cell pellet was resuspended in ice cold sterile 20 mM NaCl and
centrifuged (2420 x g, five minutes, 4°C). The supernatant was removed and cells were
resuspended in 0.4M CaC12 and centrifuged (2420 x g, five minutes, 4°C). After quickly
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decanting the supernatant, cells were resuspended in the following solution which was
made and filter-sterilized immediately prior to use: 0.056 M MnC12 ,

0.04 M CaCl2 ,

0.032 M ammonium acetate. The resulting calcium competent JM109 E. coli was then
incubated on ice for 20 minutes.
Five ng of Yeast N-Terminal Flag Expression Vector (YEp) was added to 200 µl
of calcium competent JM109 cells. To another 200 µl of the calcium competent JM109
cells 50 ng of YEp was added. Both mixtures were incubated on ice for one hour. The
cells were then heat shocked in a 42°C water bath for two minutes (to allow incorporation
of the YEp vector into cells) and placed on ice for two minutes. To the cells, 800 µl of
SOC medium [2% Bacto-tryptone; 0.5% Bacto-yeast extract; 0.05% NaCl; 20 mM
glucose (Sambrook et al., 1989)] was added. Cells were incubated at 37°C for 30 minutes
at 250 rpm and then streaked onto LB/agar plates containing 100 µg/ml of the antibiotic
ampicillin. Only cells transformed with the YEp vector (which contains the ampicillin
resistance gene) can survive in this medium. After incubating upright at room temperature
for five minutes, the plates were inverted and placed at 37°C overnight.
The next day, six tubes each containing 5 ml of liquid LB/ampicillin (100 µg/ml)
were inoculated separately with six bacteria colonies from the plates. The liquid cultures
were grown in a 37°C shaking incubator at 250 rpm overnight.

The following day,

cultures were removed from the shaker and placed at 4°C for seven hours.

An 800 µl

aliquot of cells was removed from each culture then gently vortexed with 200 µl of
glycerol and stored at -70°C as a renewable glycerol stock of the YEp vector.

The

remaining cells were harvested by centrifugation (16,000 x g, two minutes) and the
supernatants were decanted. The pellets (to be used later for isolating plasmid) were
stored at -20°C.
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YEp Plasmid Preparation (Minipreps)

To recover the YEp plasmid from the transfected JM109 E. coli, Wizard™
Minipreps (Promega Corporation, Madison, WI) were performed.

Briefly, bacterial

pellets from the six overnight cultures were lysed under alkaline conditions. The lysates
were then neutralized causing the E. coli plasma membrane and attached genomic DNA to
precipitate. The precipitated material was pelleted and the supernatants containing the
plasmid DNA were recovered. To isolate the plasmid DNA from the supernatants, a
silica-based resin was added.

After the resins were washed in high salt to remove

unbound contaminants, bound DNA was eluted in low salt Tris.IEDTA (TE) buffer [ 10
mM Tris-HCl; 1 mM EDTA, pH 8.0 (Brown, 1991)] and was stored at -20°C. Reference
the 1994 Promega Technical Bulletin, Wizard™ Minipreps DNA Purification Systems for
the detailed protocol (Promega Corporation, Madison, WI).

Restriction Endonuclease Di~estion of YEp Plasmid

To confirm that plasmid had been isolated from the bacteria, an aliquot of the
purified plasmid from each of the six YEp minipreps was digested with restriction
endonucleases and visualized on an agaroseffris-acetate/EDTA (TAE) [40 mM Trisacetate; 1 mM EDTA (Brown, 1991)] gel. Approximately 100 ng of purified YEp vector
was digested with 5 units Kpn I in Buffer A [Cp= 6 mM Tris-HCl, pH 7.5; 6 mM MgC12 ;
6 mM NaCl; 1 mM DTI (Promega Corporation, Madison, WI)] for a final reaction
volume of 20 µL After a one hour incubation at 37°C concentrated (6X) DNA loading
buffer was added to each sample for a final concentration of lX [0.042% bromophenol
blue; 0.042% xylene cyanol FF; 6.67% (w/v) sucrose in water (Sambrook et al., 1989)].
The digests were evaluated by size fractionation via electrophoresis on a 0.8%
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agaroseffAE gel containing 0.04 µg/ml of ethidium bromide. The gel was run at 100 V
for 60 minutes and the DNA was visualized using an ultraviolet transilluminator.

YEp Plasmid Modification

1. Oligonucleotide CYEpH6SWYEpH6AII) Design and Kinasing Reactions. To
provide an efficient means of protein purification, an oligonucleotide encoding a six
histidine tag was designed to be incorporated into YEp.

The sequence of the

oligonucleotides (which also encoded an Nhe I restriction site) follows:
Sense strand (YEpH6SII):
5' C/GTC/GAC/CAC/CAC/CAC/CAC/CAC/CAC/TAG/GCT/AGC/CCG/C 3'
Antisense strand (YEpH6AII):
5' GG/GCT/AGCICTNGTG/GTG/GTGIGTG/GTG/GTG/GTCIGAC/GGG/CC 3'
To prepare the oligonucleotides for a ligation reaction, a phosphate was added to the 5' hydroxyl terminus of each oligonucleotide using T4 Polynucleotide Kinase (T4 PNK).
The reaction conditions follow:
Kinasing reaction
3 µg YEpH6SII or YEpH6AII
30 Units T4 PNK
70 mM Tris-HCl, pH 7.6
10mMMgC12
5mMDTT
1.67 mM y 32P-ATP

This reaction was incubated at 37°C for 30 minutes followed by a 10 minute incubation at
65°C to inactivate the T4 PNK.

The two phosphorylated oligonucleotides were

subsequently annealed by the following reaction:
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Annealing oligonucleotides
200 ng phosphorylated YEpH6SII
200 ng phosphorylatcd YEpH6AII
40 mM Tris-HCl, pH 7.5
20mMMgC12
50mMNaCl
This mixture was first incubated in a 65°C heat block for two minutes then cooled slowly
to 37°C (to allow annealing) by placing the heat block on the lab bench.
2. Restriction Endonuclease Digestion of YEp Plasmid. To prepare the purified
YEp plasmid for ligation, 800 ng of the purified DNA was digested with 10 u,nits of Apa I
in Buffer A (Promega Corporation, Madison, WI) for a total reaction volume of 40 µl.
After incubating for 1 hour at 37°C in a heat block 10 units of Sst II were added to the
digestion and the reaction continued at 37°C for an additional two and one half hours. To
stop the reaction concentrated (6X) DNA loading buffer was added to the sample for a
final concentration of lX.

The digest was evaluated by size fractionation via

electrophoresis on a 0.8% agarosefTAE gel containing 0.04 µg/ml of ethidium bromide.
The gel was run at 100 V for 60 minutes and the DNA was visualized using an ultraviolet
transilluminator.
3.

Purification of Digested YEp Plasmid from Agarose CGeneclean™).

The

double digested YEp band was excised from the agaroseffAE gel and the DNA was
recovered using the Geneclean™ Kit (BiolOl, LaJolla, CA). Briefly, 800 µl of 6 M Nal
was added to the excised band and the mixture was incubated at 37°C for five minutes to
dissolve the agarose. GLASSMILK™ was added to the tube and after five minutes, the
GLASSMILK™/DNA complex was pelleted by centrifugation (16,000 x g, five seconds).
The supernatant was decanted and the pellet was washed three times with ice cold NEW
WASH™(BiolOl, LaJolla, CA). The pellet was desiccated for ten minutes and the DNA
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was eluted twice using 12.5 µl of 1E buffer per elution. The genecleaned product was
stored at -20°C.

4.

Li~ation

YEpH611/YEp.

The purified, double digested YEp plasmid was

centrifuged (16,000 x g, 30 seconds) to pellet any residual GLASSMILK™. A 12.5 µl
aliquot was taken from the top of the tube and added to the ligation reaction (described
below) containing the annealed YEpH611 oligonucleotide.
Li~ation

reaction

-200 ng genecleaned, Apa l/Sst II digested YEp
-100 ng annealed YEpH611 oligonucleotide
62.5 mM Tris-HCl, pH 7.6
12.5 mM MgC!i
1.25mMATP
1.25mMDTT
25% (w/v) polyethylene glycol-8000
1 unit Ligase
This reaction proceeded for four hours at room temperature.
5. Transformation of E.coli with YEpH611/YEp (mYEp). ElectroMAX DHIOB™

E. coli cells (Life Technologies, Gaithersburg, MD) were transfected with the
YEpH611/YEp ligation mix via electroporation.

Electroporation is a technique which

transiently permeabilizes bacteria cell membranes allowing foreign DNA to enter the cells.
The ligation reaction was diluted 1:5 in distilled/deionized (dd) H20 and 1 µl (3 ng)
of the diluted YEpH611/YEp ligation reaction was added to 40 µl of thawed DHlOB™
cells.

As a positive control, 1 µl (0.01 ng) of pUC19 DNA (Life Technologies,

Gaithersburg, MD) was placed in a tube with 40 µl of cells. The ligation reaction/cell
mixture was added to chilled 1 mm gap micro-electroporation cuvettes (BTX Inc., San
Diego, CA) and electroporated at 1.8 kV/cm with a time constant of 4.1 msec in the Gene
Pulser II electroporator (Bio-Rad Laboratories, Hercules, CA). One ml of SOC medium
was immediately added to the cells and the culture incubated in a 3 7°C shaking incubator
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for one hour at 250 rpm. The cells were distributed onto two LB/ampicillin agar plates
(500 µl per plate) and after one hour at room temperature the plates were inverted and
incubated overnight at 37°C. The same procedure was repeated for the positive control
pUC19 DNA.
Six colonies were selected from the YEpH6SII/YEp plates and were grown in
LB/ampicillin liquid media at 37°C, 250 rpm overnight. Plasmid DNA was isolated from
the overnight cultures (Wizard™ Miniprep) and screened for the presence of the YEpH6II
oligonucleotide by restriction analysis with Nhe I. Only the vectors which were modified
with the YEpH6II oligonucleotide (mYEp) could be linearized by a Nhe I digest, because
the oligonucleotide (and not the original YEp vector) encodes the Nhe I restriction site.
Approximately 200 ng of one of the Wizard™ purified plasmids was digested at 37°C for
one hour with 7.5 units of Nhe I in React 4 buffer [CF= 2 mM Tris-HCl, pH 7.4; 0.5 mM
MgC~;

5 mM KCl].

The YEpH6SII/YEp digest was electrophoresed on a 0.8%

agarose/TAE gel containing 0.01 µg/ml ethidium bromide and visualized on an ultraviolet
transilluminator. As a negative control, approximately 200 ng of YEp vector was digested
with Nhe I as per the above reaction conditions and was electrophoresed on the 0.8%
agarose/TAE gel with the YEpH6SII/YEp digest. As additional controls, approximately
200 ng of undigested YEp and YEpH6SII/YEp were subjected to the above reaction
conditions (with the exception of Nhe I) and size fractionated on the same gel.
Colonies that contained the YEpH6II oligonucleotide ligated into YEp (mYEp)
were amplified in LB/ampicillin liquid media at 37°C, 250 rpm overnight. Following the
overnight incubation glycerol stocks were made for storage at -70°C.
culture was used to isolate the plasmid.

The remaining
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Construction of Pfs230.C-Nterm Expression Vector

1. DNA Amplification Pfs230.C-Nterm. The polymerase chain reaction (_PCR)

was used to amplify Pfs230 region C-Nterm base pair #1339 to base pair #1752 (which
encodes amino acid 447 to amino acid 584) from P. falciparum genomic DNA (3D7
strain). Synthetic oligonucleotides that corresponded to the following base pairs in Pfs230
were used as primers in the reaction: sense oligonucleotide - base pair #1339 to base pair
#1351; antisense oligonucleotide- base pair#l719 to base pair#l752. The 5' end of the
sense oligonucleotide primer contained the sequence for the restriction enzyme Xho I,
while the 5' end of the antisense oligonucleotide primer encoded the sequence for the
restriction enzyme Apa I. These restriction enzyme sites were included to facilitate ligation
into the multiple cloning site of mYEp.
For PCR amplification, HotStart 50 tubes (Molecular-Bio Products Inc., San
Diego, CA) containing wax beads were used.

The wax served to separate upper and

lower layer components until the reaction had begun and to prevent evaporation during the
reaction cycles. Lower layer components of the reaction were added to the tube in the
following proportions :
Lower layer components
0.4mM dNTP
2mMMgC12
50mMKCl
10 mM Tris-HCl, pH 9.0 (at 25°C)
1% TritonX-100
600 ng sense primer
600 ng antisense primer
Reaction tubes were incubated in a thermocycler (MJ Research Inc., Watertown, MA) at
90°C for 30 seconds then cooled to 4°C for five minutes to melt the wax bead over the
lower layer. Upper layer components were then added to the reaction tube as follows:
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Upper layer components
-1 µg 3D7 P. falciparum genomic DNA
2mMMgC~

50mMKCl
10 mM Tris-HCl, pH 9.0 (at 25°C)
1% Triton X-100
5 units Taq polymerase
Initially, the reaction tubes were sequentially incubated (94°C for one minute; 38°C for 30
seconds; 72°C for two minutes) to initiate the mixing of the reaction components. The
PCR was then begun using the following program:
PCR Reaction
(A)
(B)
(C)
(D)

(E)

INITIAL DENATURATION -- 94°C for 30 seconds
ANNEALING OF PRIMERS -- 38°C for 30 seconds
EXTENSION OF PRIMERS -- 72°C for 2 minutes
REPEAT STEPS A-C -- 30 cycles
FINAL EXTENSION OF PCR PRODUCTS -- 72°C for 6 minutes

The size of the PCR amplified DNA was evaluated via electrophoresis on a 1.2%
agaroseffAE gel containing 0.07 µg/ml ethidium bromide.

DNA loading buffer was

added to 2 µl samples of the PCR reaction. The gel was electrophoresed at 100 V for 60
minutes and DNA was visualized using an ultraviolet transilluminator.
The remaining PCR product was concentrated by ethanol (EtOH) precipitation.
Briefly, 5 M ammonium acetate was added to the PCR sample to a final concentration of
2.5 M. Ninety-five percent EtOH was added to the PCR amplified DNA to a final
concentration of 63.33%. The sample was then incubated at 4°C for 48 hours, then
centrifuged (16,000 x g, 20 minutes) and the supernatant decanted. The pellet was then
dried and washed with 100 µl of 95% EtOH and centrifuged (16,000 x g) for an additional
ten minutes. The supernatant was removed and the C-Nterm pellet was vacuum dried for
three minutes and stored at -20°C until use.
2. Restriction Endonuclease Digestion of C-Nterm and mYEp. The amplified CNterm pellet was digested with restriction endonucleases to generate compatible ends for
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ligation into mYEp. The estimated 5 µg C-Nterm pellet was resuspended in React 2 buffer
[CF= 5 mM Tris-HCI, pH 8.0; 1 mM MgC1 2 ; 5 mM NaCIJ and 25 units of Xlw l

(Promega Corporation, Madison, WI) were added to start the reaction. The reaction was
incubated at 37°C for one hour and 15 minutes then EtOH precipitated (as described
previously) using 5 M ammonium acetate and 95% EtOH. The Xho I-digested C-Nterm
pellet was then resuspended in React 4 buffer and 25 units of Apa I were added to begin
the second digestion. This reaction was incubated at 37°C for one hour and DNA loading
buffer was added to stop the reaction.
mYEp was isolated from an overnight culture of bacterial cells transfected with the
mYEp plasmid using the QIAprep Spin Plasmid Miniprep Kit (50) (Qiagen Inc.,
Chatsworth, CA). Briefly, bacterial cells were lysed in NaOH/sodium dodecyl sulfate
(SDS) in the presence of RNase.

The salt concentration of the cell lysate was then

increased, causing chromosomal DNA to precipitate. Genomic DNA was removed by
centrifugation and the cleared supernatant was loaded onto a QIAprep spin column which
has a silica based membrane that selectively adsorbs DNA After washing the QIAprep
spin column, the mYEp DNA was eluted with 50 µl TE buffer.
Qiagen purified mYEp (-500 ng) was digested with 10 units of Xho I in React 2
buffer for one hour at 37°C. The DNA was then EtOH precipitated using 5 M ammonium
acetate and 95% EtOH. The resultant Xho I-digested mYEp pellet was resuspended in
React 4 buffer and 10 units of Apa I and then incubated for one hour and 20 minutes at
37°C. The reaction was stopped by the addition of DNA loading buffer to the sample.
The C-Nterm and mYEp samples were electrophoresed on a 1.2% agaroseffAE gel
containing 0.04 µg/ml ethidium bromide for one hour at 114 V. The gel was visualized on
an ultraviolet transilluminator for a very short time and the bands representing digested CNterm and digested mYEp were excised. The digested DNA was extracted from the
agarose and purified using the Geneclean™ Kit (BiolOl, LaJolla, CA) as described in the
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YEp plasmid modification section of this chapter. The genecleaned products were stored
at -20°C.
3. Ligation C-Nterm/mYEp. Because both C-Nterm and mYEp were digested
with the same restriction endonucleases, it was possible to perform a compatible end
ligation reaction. The reaction conditions follow:
Ligation reaction
-180ng mYEp
-48 ng C-Nterm
62.5 mM Tris-HCl, pH 7.6
12.5 mM MgCl2
1.25mMATP
1.25 DTT
25% (w/v) polyethylene glycol-8000
1 unit Ligase
This reaction incubated at room temperature for four and one half hours. The reaction was
then EtOH precipitated using 5 M ammonium acetate and 95% EtOH.

The ligation

reaction pellet was resuspended in 10 µl ddH20 and used to transfect E. coli.
4. Transformation of E. coli with C-Nterm/mYEp construct. One µl (20 ng) of
the precipitated C-Nterm/mYEp ligation reaction was added to 20 µl of ElectroMAX
DHlOB™ E. coli cells (Life Technologies, Gaithersburg, MD) and the mixture was
placed in a chilled 1 mm gap disposable micro-electroporation cuvette (BTX, San Diego,
CA). One µl (0.01 ng) pUC19 DNA (Life Technologies, Gaithersburg, MD) in 20 µl of
DHlOB™ cells served as a positive control. A 1.7 kV charge was administered using the
TransPorator™ Plus (BTX, San Diego, CA). The C-Nterm/mYEp transfected E. coli
from two electroporations were combined in 1 ml of SOC medium.

The cells were

incubated for one hour at 37°C, in a 250 rpm shaker and then distributed equally onto two
LB/ampicillin agar plates. After a five minutes incubation upright, the plates were inverted
and incubated at 37°C overnight. The following day, resultant colonies were selected
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from the plates and amplified in LB/ampicillin liquid media overnight at 37°C in a 250 rpm
shaking incubator. The same procedure was followed for the cells transfected with the
positive control pUC19 DNA.
Cells were harvested from the amplified colonies and plasmid was isolated using
the QIAprep Spin Plasmid Miniprep Kit. The isolated plasmids were digested with Kpn I
and Spe I which are 5' and 3' to the multiple cloning site in mYEp, respectively.
Approximately 100 ng of isolated plasmid (C-Nterm/mYEp) was digested with 10 units of
Kpn I and 10 units of Spe I in React 4 at 37°C for one hour. DNA loading buffer was
added to stop the reaction.

The digestion reaction was electrophoresed on a 1. 0%

agaroseffAE gel containing 0.01 µg/ml ethidium bromide at 100 V for one hour and the
DNA was visualized on an ultraviolet transilluminator.
Colonies that contained the C-Nterm/mYEp construct were amplified in
LB/ampicillin liquid media overnight at 37°C, 250 rpm and were then stored as glycerol
stocks at -70°C.

Manual DNA SeQJlencin~

To confirm the proper reading frame of the C-Nterm/mYEp construct manual
sequencing was done using the Sequenase™ Version 2.0 DNA Sequencing Kit
(Amersham, Cleveland, OH). Unless otherwise indicated, all enzymes and buffers used
for the sequencing reactions were sold with that kit. One µg of C-Nterm/mYEp was
resuspended in 18 µl ddH20 and 2 µl NaOH, incubated at 37°C for five minutes, then
EtOH precipitated. Following incubation on dry ice for 10 minutes, the precipitate was
pelleted by centrifugation (16,000 x g, 20 minutes) and the supernatant was decanted.
The C-Nterm/mYEp template pellet was washed with 95% EtOH, centrifuged (16,000 x
g, 10 minutes) and the supernatant discarded. The template was resuspended in 2.0 µl of
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Sequenase Reaction Buffer and 3.5 pmol of Ya.N-21 primer (Eastman Kodak Company,
New Haven, CT), heated for two minutes at 65°C in a heat block, then cooled slowly to
37°C by placing the heat block on the lab bench.
To the cooled template/primer mixture, the following were added: 1 µl DTT ( 100
mM); 2.0 µl of 1:10 diluted Labeling Mix (1 µl Labeling Mix in 10 µl ddH 20).

The

reaction was started by the addition of 20 µCi [35 S] dATP and 2 µl of 1:8 diluted
Sequenase/buffer solution (1 µl (13 units) Sequenase in 8 µl of Enzyme Dilution Buffer).
After three and one half minutes at room temperature, a 3 µl aliquot of the reaction mixture
was added to four tubes each containing 2.5 µl (0.8 µM) of a distinct ddNTP. The tubes
were incubated for seven minutes at 37°C after which time 4 µl of Stop Solution was
added. The reactions were stored at-20°C until the following day.
Premixed

6%

polyacrylamide

gel casting

solution

(Life Technologies,

Gaithersburg, MD) was used to pour the sequencing gel. Eight hundred µl of 10%
ammonium persulfate was added to the 7 5 ml gel mix solution immediately prior to
pouring the gel. The sequencing gel polymerized overnight at room temperature.
The fohowing day, the polymerized gel was mounted on the running apparatus and
lX Tris-borate/EDTA (TBE) [0.09 M Tris-borate; 0.002 M EDTA (Brown, 1991)] was
added as a running buffer. The power supply was set at 1220 V, 55 mA, 69 W to warm
the gel before the samples were loaded. Just before loading, the samples were heated for
three minutes at 75°C and placed immediately on ice. Three µl from each ddNTP/reaction
tube was added to a separate well. A long sequencing run (4 hours) was done for optimal
resolution of larger bands and a short sequencing run (2 hours) was done for optimal
resolution of smaller bands. The gel was electrophoresed at 1220 V, 55, 71 W.
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At the end of the run, the gel was removed from the apparatus and fixed in 10%
methanol (MeOH), 10% glacial acetic acid for one hour at room temperature. The gel was
then dried for one and one half hours at 80°C and used to expose X-ray film .. The
autoradiogram was developed and the sequence of C-Nterm/m YEp was read.

Transformation of S. cerevisiae with C-Nterm/mYEp Construct

Liquid YPD growth media [l % Bacto-yeast Extract; 2% Bacto-peptone; 2% Bacto
dextrose (Eastman Kodak Company, 1994)] was inoculated with S. cerevisiae (2095-6
strain) and incubated at 30°C for 72 hours at 250 rpm. When the OD 600 of the culture was
1.3, cells were harvested by centrifugation (5,000 x g, five minutes, room temperature).
The supernatant was decanted and cells were resuspended in 10 ml YPD and 200 µl 1 M
HEPES, pH 8.0. Sterile, cold ddH 20 was added to the resuspended cells to increase the
volume to 25 ml. While swirling gently, 275 µl of 0.9 M cold DTT was added. The cells
were pelleted by centrifugation (5,000 x g, five minutes, 4°C) and washed sequentially in
30 ml sterile, cold ddH20; 25 ml sterile, cold ddH20; 2 ml sterile, cold 1 M sorbitol.
Following the washes, the cells were pelleted by centrifugation (5,000 x g, five minutes,
4°C) then vigorously resuspended in 50 µl sterile, cold 1 M sorbitol.
Twenty five ng of the C-Nterm/mYEp construct was added to 40 µl of the washed
S. cerevisiae cells and the mixture was placed in a sterile, chilled 2 mm gap electroporation
cuvette.

Using the TransPorator™ Plus (BTX, San Diego, CA), the yeast was

electroporated at 1.5 kV then immediately diluted with 1 ml cold 1 M sorbitol and gently
resuspended. Five hundred µl of cells were plated onto two synthetic complete medium
(SCM) minus tryptophan (TRP) plates (Bio 101, La Jolla, CA) and incubated at 30°C for
48 hours, inverted. Only yeast transfected with the mYEp expression vector can survive
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on TRP minus media because mYEp encodes a TRP selectable marker. Thus, colonies
that grew on SCM minus TRP plates should contain mYEP.
Colonies were selected from the plates and grown in liquid SCM minus TRP for
72 hours at 30°C, 250 rpm to an OD600 of ~ 8.0. Glycerol stocks [333 µl 60% glycerol;
667 µl yeast culture] were made and stored at -70°C.

An aliquot was also taken to

inoculate a culture that would be used for protein expression work.

Inducin~

Protein Expression in S. cerevisiae Transformants

A 2.5 µl aliquot of the SCM minus TRP culture described above was diluted 1:20
in each of three tubes containing 47.5 ml YP4 High Stability Expression Media (YPHSM)
[1 % dextrose; 3% glycerol; 1% Bacto-yeast extract; 8% Bacto-peptone; 20 mM CaC12 ;

0.05% adenine; 0.05% uracil (Eastman Kodak Company, 1994)] and were incubated at
30°C for 72 hours at 250 rpm. The cultures were harvested and the cells pelleted by
centrifugation (16,000 x g, 20 minutes, 4°C). The supematants were saved and later
evaluated for the presence of secreted recombinant protein.

Trichloroacetic Acid (fCA) Precipitation and SDS-Polyacrylamide Gel Electrophoresis
(PAGE)

To better visualize proteins secreted by yeast, 500 µl of each of the three yeast
expression culture supematants were concentrated by precipitation with 125 µl 100%
TCA. After centrifugation (16,000 x g, 20 minutes) the supematants were decanted and
the pelleted proteins were washed three times in 500 µl

ac~tone

and again centrifuged
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(I6,000 x g, five minutes, 4°C). The pellets were resuspended in 50 µl IX sample buffer
L0.134 M Tris-base, pH 6.8; I% SDS (w/v); 10% glycerol; 0.08% bromophcnol blue
(w/v) (Harlow and Lane, I988)], 5%

~-mercaptoethanol

and size fractionated on a

denaturing I2% polyacrylamide separating gel, 3.75% polyacrylamide stacking gel using
electrophoresis buffer [25 mM Tris-base; 200 mM glycine; O. I% SDS (Sambrook et al.,
I989)]. The gel was electrophoresed at I76 V, 36 mA for two hours and stained in
Coomassie brilliant blue [10% glacial acetic acid; 45% MeOH; O. I% Coomassie brilliant
blue (w/v)(Sigma Chemical Company, St. Louis, MO)] overnight while shaking. The gel
was destained [5% MeOH, 7.5% glacial acetic acid] on a shaking plate and protein was
visualized over a light source.

Ni2+-NTA Purification of Recombinant C-Nterm Protein

An Ni 2+-NTA affinity column was used to purify recombinant C-Nterm from the

yeast expression media supernatant.

Ni2+-NTA resin (Qiagen Inc., Chatsworth, CA)

binds the six histidine tagged C-Nterm due to a high affinity interaction between the six
consecutive histidines and the Ni2+-NTA complex.

Find a detailed reference for the

procedure explained below in The QIAexpressionist, Summer, I992 manual (Qiagen Inc.,
Chatsworth, CA).
Fifty ml of supernatant from one yeast expression culture was dialyzed against 2
liters of IX phosphate-buffered saline (PBS) [8.0 g/L NaCl; 0.34 g/L KH 2P04 ; 1.21 g/L
K 2HP0 4 , pH 7.3 (Brown, I99I)] in Spectra/Par 4 dialysis membrane tubing (molecular
weight cut off: I2-I4,000)(Baxter Diagnostics Inc., McGaw Park, IL) for four hours at
4°C. The tubing which contained the supernatant was then transferred to 2 liters of fresh
IX PBS and was incubated at 4°C overnight. The following day, 1.5 ml of the Ni2+-NTA
resin equilibrated with Column buffer [50 mM Na-P0 4 , pH 8.0; 300 mM NaCl (Qiagen
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Inc., 1992)] and was added to the dialyzed yeast supernatant. The supernatant/resin slurry
was incubated on ice and placed on a shaking plate for one hour.

The slurry was

subsequently loaded onto two poly-prep chromatography columns (Bio-Rad LaboraLories,
Hercules, CA) and the material which did not bind to the columns was collected. (After
this step, all fractions were collected in 1.0 ml amounts, with the exception of the first
fraction from each separate wash which was collected in 200-300 µl fractions). The resin
was washed with 5 ml Wash buffer [50 mM Na-P0 4 ; 30 mM NaCl; 10% glycerol, pH 7 .0
(Qiagen Inc., 1992)] then 5 ml Wash buffer containing 0.5 M imidazole, pH 7.0 was
applied to elute C-Nterm. Subsequent washes with 5 ml Wash buffer, pH 6.0 and then 5
ml Wash buffer, pH 4.5 were performed to be sure protein had been eluted from the

column. Eluants were stored at 4°C.
To determine which fraction contained the eluted C-Nterm protein, aliquots from
the eluted fractions were analyzed on denaturing 12% polyacrylamide separating gels,
3.75% polyacrylamide stacking gels. The gels ran at 176 V, 36 mA, 92 minutes then 120
V, 92 mA for an additional 28 minutes and proteins were visualized by Coomassie blue
staining.

Western Blot Analysis of Ni2+-NTA Purified Protein

To determine if protein eluted from the Nf+-NTA affinity columns reacted with
antibodies generated against Pfs230, it was analyzed by western blot.

Proteins size

fractionated by SDS-PAGE were electrophoretically transferred to a nitrocellulose
membrane for one hour at 100 V using chilled transfer buffer [25 mM Tris-base; 200 mM
glycine; 20% MeOH (Harlow and Lane, 1988)]. Following the transfer, the nitrocellulose
filter was blocked in 5% dry milk/lX PBS for 15 minutes at room temperature to prevent
non-specific antibody binding. The filter was then incubated overnight at 4°C with the
indicated primary antibodies diluted 1:2000 in lX PBS.

The following day, the
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membranes were washed three times with lX PBS and then incubated for 45 minutes at
room temperature with the secondary antibodies, Goat-Anti-Mouse IgG alkaline
phosphatase conjugate (Sigma Chemical Company, St. Louis, MO) diluted 1:2000 in lX
PBS. The filter was then washed twice with lX PBS and once with alkaline phosphatase
buffer [100 mM NaCl; 5 mM MgC12 ; 100 mM Tris-base, pH 9.5 (Harlow and Lane,
1988)]. The membrane was subsequently incubated with 16.5 µl 5-bromo-4-chloro-3indolylphosphate p-toludine salt (BCIP) (Life Technologies, Gaithersburg, MD), 22 µl
Nitroblue tetrazolium chloride (NBT) (Life Technologies, Gaithersburg, MD) in 5 ml
alkaline phosphatase buffer. Bound antibody was visualized by the formation of a blue
precipitate on the nitrocellulose.

Glycoprotein Detection Assay

In contrast to P. falciparum,

proteins secreted by yeast are often post-

translationally modified by the addition of large branches of carbohydrates (i.e. mannoses)
to a secreted protein.

This process is known as glycosylation.

To determine if

recombinant C-Nterm was glycosylated, the DIG Glycan Detection Kit (Boehringer
Mannheim, Indianapolis, IN) was used. Unless otherwise referenced, chemicals used for
this experiment were supplied with the kit.
The samples were first electrophoresed on a denaturing 12% polyacrylamide
separating gel, 3.75% polyacrylamide stacking gel for 20 minutes, 150 V, 36 mA and
continued for 70 minutes, 174 V, 36 mA.

Samples were then electrophoretically

transferred to nitrocellulose for one hour at 100 V in chilled transfer buffer. Following the
transfer, the nitrocellulose was washed two times in lX PBS, pH 6.8.

To oxidize the

glycoproteins, the filter was subsequently incubated in sodium metaperiodate for 20
minutes while shaking at room temperature. After washing the filter three times for 10
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minutes each in lX PBS, the membrane was incubated in 1 µl DIG-0-3-succinyl-£aminocaproic acid hydrazide dissolved in 5 ml sodium acetate buffer, pH 5.5, for one
hour, shaking at room temperature. Proteins were then stained with ponceau S for five
minutes (while shaking) to determine if the transfer was successful and to identify the
major protein bands present. Following this, the nitrocellulose was incubated in Blocking
Reagent for one hour at room temperature and then the filter was washed three times for
10 minutes each with lX Tris-buffered saline (TBS) [0.05 M Tris-HCl; 0.15 M NaCl, pH
7 .5 (Boehringer Mannheim, 1995)] while shaking. The nitrocellulose was then probed
with 10 µl alkaline phosphatase labeled Anti-digoxigenin antibodies in 10 ml lX TBS
overnight at 4°C. The following day, the filter was washed three times for 10 minutes
each with lX TBS. Staining solution [10 ml alkaline phosphatase buffer, pH 9.5; 37.5 µl
X-phosphate; 50 µl NBT (Boehringer Mannheim, 1995)] made immediately prior to use,
was added to the filter to visualize reactivity with glycosylated proteins which was
observed by the presence of bands on the nitrocellulose.

C-Nterm Protein Sequencin~

To directly determine the identity of the highest molecular weight band produced
by C-Nterm/mYEp transfected yeast, the amino acid sequence of that protein was
evaluated.

Twenty-four ml (-2 µg) of supernatant from yeast transfected with C-

Nterm/mYEp construct was concentrated by adding it to SpectraPor dialysis tubing then
placing the tubing in one and one half cups of chilled, ground sucrose. As the volume of
the supernatant progressively decreased, knots were tied to keep the tubing tight around
the supernatant. After nine hours the volume of the supernatant was approximately 5 ml.
Three ml of concentrated C-Nterm/mYEp yeast transfected supernatant was sent to Dr.
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Bassam Wakim, PhD at Loyola University Medical Center in Maywood, IL. Dr. Wakim
purified the highest molecular weight band of the recombinant protein by High
Performance Liquid Chromatography (HPLC) using a C4 reversed phase column.

A

fraction of the purified protein was subjected to Staphylococcus aureus (V8) protease
digestion and peptides were then purified by HPLC using a C4 reversed phase column.
The amino acid sequence of selected peptides was obtained.

Yeast Spheroplast Preparation/DNAExtraction

To determine if the C-Ntenn/mYEp construct had been altered after transfection
into the yeast, the plasmid was recovered from yeast and transfected into E. coli. The
plasmid was isolated from the E. coli, purified, and then sent for automated DNA
sequencing.
More specifically, to do this, sterile YPD media was inoculated with the CNtenn/mYEp yeast glycerol stock and incubated at 225 rpm, overnight in a 30°C shaking
incubator. The following day, when the OD600 was 1.3, the culture was centrifuged
(2,000 x g, 15 minutes, room temperature) and the supernatant was decanted. The cell
pellet was resuspended in 20 ml of 1 M sorbitol, 20 mM Tris-base, pH 8.0 and then
centrifuged (2,000 x g, 20 minutes, room temperature).

After the supernatant was

decanted, the cell pellet was resuspended in 2 ml of 20 mM sodium citrate, pH 5.8; 1 M
sorbitol; 2 mg lyticase (Boehringer Mannheim, Indianapolis, IN) and incubated at 37°C
for 30 minutes.

This mixture was then centrifuged (2040 x g, five minutes, room

temperature), the supernatant decanted and the cells resuspended in 1 ml of 0.1 M EDTA,
pH 8.0; 10 mM Tris-base; 1% sarkosyl; 2 mg proteinase K. The resuspended cells were
placed at 30°C for 30 minutes then 65°C for 15 minutes. The mixture was brought up to a
final volume of 10 ml by adding ddH 20 and centrifuged (23,420 x g, 25 minutes, 4° C).
To the resultant supernatant, 1/10 the volume of 5 M ammonium acetate and one volume
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of isopropanol were added. After the supernatant incubated for 10 minutes at -20°C, the
mixture was centrifuged (26,890 x g, 15 minutes, 4°C). The supernatant was decanted
and the resultant pellet was resuspended in 500 µl ddH 20. Fifty µg RNase was added to
the tube and the mixture incubated at 37°C for 30 minutes. To remove proteins, a phenol
extraction was done by adding 500 µl of Tris-saturated phenol, pH 7 .9 and centrifuging
the mixture (16,000 x g, 15 minutes, room temperature). The top layer containing the
DNA was recovered, transferred to a new tube and the above step was repeated twice
more.

To the recovered DNA, 200 µl chloroform was added and the mixture was

centrifuged at 16,000 x g for 15 minutes.

The DNA (top layer) was recovered and

precipitated overnight at -20°C with one half the volume of 5 M ammonium acetate and
two times the total volume of 95% EtOH. The following day, the DNA was centrifuged
(16,000 x g, 20 minutes). The supernatant was decanted and the pellet was resuspended
in 100 µ195% EtOH, centrifuged (16,000 x g, 10 minutes) and the resultant supernatant
was decanted. The pellet was resuspended in 20 µl of filter-sterilized TE buffer, pH 8.0.

Transformation of E. coli with yC-Ntenn/m YEp Construct Recovered from S. cerevisiae

The DNA obtained from yeast as described above was electroporated into E. coli.
One µI of DNA was added to 20 µI ElectroMAX E. coli

DHlOB™ cells (Life

Technologies, Gaithersburg, MD) and electroporated at 1.7 kV. This step was repeated
and both sets of electroporated cells were immediately combined into 1 ml SOC media.
After incubating the culture at 37°C, 225 rpm for one hour, the cells were distributed onto
LB/ampicillin agar plates and incubated overnight at 37°C. Only the colonies containing
the construct recovered from the yeast (yC-Nterm/m YEp) can survive on this medium due
to the presence of the ampicillin resistance gene in the mYEp vector. The following day,
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colonies were selected from the plates and grown in LB/ampicillin liquid media overnight
at 37°C, 250 rpm.
Plasmid was isolated from the overnight culture by the Qiagen method and was
evaluated by restriction analysis.

Approximately 100 ng of Qiagen purified yC-

Nterm/mYEp was digested with five units of Kpn I and five units of Spe I in lX React 4
buffer. The reaction was incubated at 37°C for one hour and 6X DNA loading buffer was
added to stop the reaction.

The digestion reaction was electrophoresed on a 1.0%

agaroseffAE gel, 0.02 µg/ml ethidium bromide at 100 V for 70 minutes. The gel was
destained in ddH 20 at 4°C for three hours and the DNA was visualized on an ultraviolet
transilluminator.

Automated DNA Seguencin~ yC-Nterm/mYEp Construct

To confirm that the construct recovered from the yeast (yC-Nterm/mYEp) was in
the proper reading frame and to determine if the sequence had been altered by the yeast,
1.2 µg of the Qiagen purified yC-Nterm/mYEp was sent for automated sequencing at the
University of Chicago (University of Chicago Sequencing Facility, Chicago, IL). The
sequence obtained was analyzed using EditView ABI Automated DNA Sequence Viewer,
Version 1.0 (Perkin Elmer Corporation, 1996).

CHAPTER III
RESULTS

Vector Modification

To generate S. cerevisiae-produced Pfs230 the first step taken was to produce
ample quantities of the Yeast N-Terminal Flag Expression Vector (YEp) purchased from
Eastman Kodak. Towards that end, E. coli strain JM109 was transfected with the YEp
vector. Because YEp encodes a gene which confers ampicillin resistance, transfected
bacteria was grown and selected for on LB/ampicillin agar plates. Twenty three colonies
grew on the plate which contained bacteria transfected with 5 ng of YEp. Twenty colonies
grew on the plate which contained bacteria transfected with 50 ng of YEp. Of these, six
colonies were selected (three from each plate) and grown separately in LB/ampicillin liquid
to generate a clonal population of each colony. Bacteria harvested from the six cultures
were lysed and the YEp vector was purified and digested with Kpn I. The digests were
electrophoresed on an agarose/TAE gel to verify that YEp vector was purified (Figure 2).
Bands from five of the six digests were found to be 7 .37 kB as interpolated by DNA size
standards. The actual size of YEp is 7.2 kB. No plasmid was recovered from the sixth
colony. Purified vector obtained from one of the transfected colonies was used for
subsequent modification.
The purified YEp was modified to encode a six histidine tag and a Nhe I restriction
site at the 3' end of the multiple cloning site. The six histidines encoded by the modified
YEp

vector

(m YEp)

were

to

be expressed

41

on

the

carboxy

terminus

of

42

1

2

3

4

5

6

--9.4kB
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Figure 2 . Kpn I digests of YEp vector. Plasmid was Qiagen purified from six colonies of
JM109 E. coli transfected with the YEp vector. The purified material was digested with
Kpn I and then size fractionated on a 0.8% agaroseffAE gel. Lanes 1-6 contain Kpn I
digested material purified from bacterial colonies 1-6, respectively. DNA size standards
are indicated on the right.
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C-Nterm protein thus enabling the recombinant protein to be purified using a Ni 2+-NTA
affinity column.

Briefly, two synthetic complementary oligonucleotides (sense and

antisense) which encoded for a six histidine tag and a Nhe I restriction site _were
phosphorylated and annealed together (Figure 3).

The annealed oligonucleotide

(YEpH6II) was then ligated into the YEp plasmid which had also been previously digested
with Apa I and Sst II.

Annealed oligonucleotide YEpH6II

Alla.I
Six His STOP
Nhe I
Sst II
STOP
ggg/ eeC I GTC I GAC I 6 x CACI TAG I GCT I AGC I CCG I Cgg I taa
r,.CC/ GOO I CAG I CTG I 6 x GTG I ATC I CGN TCG I GGe I gee I att

Figure 3. This schematic shows the annealed oligonucleotide which was ligated into the
YEp vector to encode for six consecutive histidines, a stop codon, and a Nhe I restriction
site. The oligonucleotides were phosphorylated, annealed together, and ligated into the
YEp vector via a compatible end ligation into the Apa I and Sst II restriction sites. The
YEpH611/YEp ligation generated a modified (mYEp) vector which differed from YEp at
the 3' end of the multiple cloning site. Lower case, bolded and underlined letters represent
the vector sequence and the upper case letters represent the synthetic oligonucleotide
sequence.

E. coli was transfected with the YEpH611/YEp ligation mix and plated out onto
LB/ampicillin agar plates.

Resultant colonies were counted to determine the

transformation efficiency. This number was compared to the transformation efficiency of

E. coli that was transfected with the positive control DNA, pUC19 monomer.
equation used to determine the transformation efficiency follows:

The
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Colony forming units (CFU)/µg

=CFU in pUC19 plate* 1x106 pg* dilution factor
pg pUC19 used

µg

The transformation efficiency calculated for the control, pUC19, plate follows:
CFU/µg

= 150 CFU * 1 x 106 pg * 100 = 1.5 x 109
10 pg

µg

The transformation efficiency calculated for the mYEp construct follows:
CFU/µg

= 32 CFU * 1 x 106 pg *2 = 2.56 x 104
2.5 x 103 pg

µg

Six mYEp colonies were selected and grown up overnight in liquid culture.
Plasmid was isolated and analyzed for the presence of the synthetic oligonucleotide by
restriction analysis using Nhe I. Because only the plasmid containing YEpH611 (m YEp)
contains a Nhe I restriction site (and unmodified YEp does not) mYEp plasmids can be
linearized by a Nhe I digestion while YEp plasmids cannot. Linearized vector would be
represented by a band migrating at approximately 7.2 kB.

Undigested vector (which

should be seen in the negative control YEp Nhe I digest) would be seen as two bands: one
just above 7 .2 kB representing relaxed plasmid; one just below 7 .2 kB representing
supercoiled plasmid. The mYEp and YEp Nhe I digests were electrophoresed on a 0.8%
agaroseffAE gel containing 0.01 µg/ml ethidium bromide and were visualized using an
ultraviolet transilluminator. Plasmid from a mYEp colony migrated as one 10.68 kB band
(as interpolated by size standards using linear regression) following the Nhe I digestion
suggesting that this plasmid contained the synthetic oligonucleotide (Figure 4). The actual
size of mYEp is 7.206 kB. The control YEp plasmid Nhe I digest migrated as two bands,
one interpolated at 11.5 kB and one interpolated at 6.29 kB, consistent with the pattern of
relaxed and supercoiled plasmid (Figure 4). Both uncut YEp and uncut mYEp which were
run as controls, also migrated as two bands at 11.5 kB and 6.29 kB.
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--23.1 kB
9.4 kB
6.6kB

2.3 kB
1.3 kB
1.1 kB
- - .872kB
- - .602kB

- - .310kB

Figure 4. Size fractionation of YEp and m YEp Nhe I digests. Reactions were size .
fractionated on a 0.8% agarose/TAE gel, 0.01 mg/µl ethidium bromide. Undigested YEp
and m YEp were run as controls. Lane 1 contains 5 µl undigested YEp vector . Lane 2
contains 5 µl of YEp vector digested with Nhe I. DNA standards are seen in lane 3 and
the corresponding sizes are indicated on the right. Lane 4 contains 5 µl mYEp vector
digested with Nhe I. Lane 5 contains 5 µl of undigested m YEp.
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Pfs230 Expression Vector

Using mYEp, a Pfs230 expression vector was constructed. To do this, _DNA
encoding region C-Nterm (base pair #1339 to base pair #1752 of Pfs230) was amplified
by PCR. Sense and antisense primers which encoded Xho I and Apa I, respectively, at
the 5' end were used in the reaction. The size of the PCR amplified DNA was evaluated
via electrophoresis on a 1.2% agaroseffAE gel containing 0.007 µg/ml ethidium bromide
and was found to be 473 base pairs by interpolation against size standards. This was
consistent with the predicted 414 base pair size of Pfs230.C-Nterm and thus suggested
that the appropriate region of Pfs230 had been amplified (Figure 5).
To facilitate insertion of PCR amplified C-Nterm into the mYEp vector (Figure 6)
both were digested with Xho I and Apa I generating compatible ends.

The double

digested PCR product and vector were size fractionated on a 1.2% agaroseffAE gel. The
corresponding bands were isolated and the DNA was recovered from the agarose and
genecleaned. The 7.2 kB mYEp vector and the 414 base pair PCR amplified C-Nterm
were ligated together and electroporated into E. coli.

The bacteria was plated onto

LB/ampicillin agar and the transformation efficiency for the C-Nterm/mYEp construct was
calculated as follows:
CFU/µg

= 200 CFU * 1x106 * 2 = 8.7 x 103
4.56 x 104 pg

µg

The transformation efficiency for the positive control pUC19 was calculated as follows:
CFU/µg = 200 CFU
10 pg

* 1 x 106 * 100 = 2 x 109
µg

Three ampicillin resistant colonies were selected, grown up, and the plasmid was isolated.
Plasmid was digested with Kpn I and Spe I and size fractionated on a 1.0% agaroseffAE
gel.

The cleavage site for Kpn I in mYEp is base pair #1457.

The cleavage
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23.1 kB
9.4kB
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_
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Figure 5. Size fractionation of PCR amplified Pfs230.C-Nterm. Primers designed to
flank the sequence of Pfs230.C-Nterm were used to amplify this region via the
polymerase chain reaction and the products obtained were size fractionated on a 1. 2 %
agaroseffAE gel. DNA size standards appear in lane 1 and the corresponding sizes are
indicated on the right. Lanes 2 and 3 each contain 2 µl of the PCR amplified product.
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Pfs230.C-Nterm

Alpha

FLAG

Multiple Cloning Site
Xho I Apa I

6 His Nhe I STOP

mYEp vector
7.205 kB

Spe I

Figure 6. Schematic representing the mYEp vector. The position of the restriction sites
that were used in this project are indicated. The relative location of the six histidine tag,
the FLAG peptide and stop codons are also indicated.
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site for Spe I in mYEp is base pair #2031. Thus if a mYEp vector without C-Nterm insert
was digested with these enzymes, two fragmentc; would result one at 6.626 hase pairs
representing the vector; one at 57 4 base pairs representing the area of the vector between
Kpn I and Spe I. If mYEp contained the C-Nterm insert, a digest would result in two
fragments on an agaroseffAE gel: mYEp at 6.626 kB; C-Nterm at approximately 988
base pairs (the 414 base pair C-Nterm fragment plus the 574 bases between Kpn I and Spe
I). Two out of three colonies selected were digested with Kpn I and Spe I. Plasmid from
one of these colonies is seen in Figure 7 and migrated as two fragments on the
agaroseffAE gel: one interpolated against size standards to be 7.95 kB; one interpolated
against size standards to be 931 base pairs (Figure 7). These results suggest that the PCR
product had been ligated into mYEp. As a control, a sample of the original mYEp which
had not been ligated with C-Nterm insert, was also digested with Kpn I and Spe I.

In

contrast to the digest of the plasmid purified from C-Nterm/mYEp transfected bacteria, the
mYEp digest resulted in a band extrapolated against size standards to be 7.95 kB and a
band extrapolated against size standards to be 555 base pairs.

Manual DNA Sequencing

To confirm that the C-Nterm/mYEp construct had been ligated together in the
proper reading frame, the Qiagen purified C-Nterm/mYEp DNA was manually sequenced.
Sequencing reactions were performed and then electrophoresed on a 6% polyacrylamide
gel. An autoradiograph of the sequencing gel was read from base pair #1493 to base pair
#1507 in the vector and base pair #1 to base pair #263 in C-Nterm (Figure 8). This was
compared with the reported sequence of C-Nterm/mYEp (Figure 8) to verify the proper
reading frame. The vector sequence that was read from the autoradiograph was identical
to the reported sequence of mYEp base pair #1493 to base pair #1507. However, one
discrepancy was identified between the manual sequence of Pfs230.C-Nterm and the
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1

2
--9.4kB
--6.6kB

--1.lkB
--.872kB

Figure 7. Kpn I and Spe I digests of mYEp and C-Nterm/mYEp. The constructs were
digested and size fractionated on a 1% agaroseffAE gel. Lane 1 contains 10 µl of mYEp
cut with Kpn I and Spe I. Lane 2 contains 10 µl C-Nterm/mYEp cut with Kpn I and Spe
I. The weights of DNA molecular size standards are indicated on the right.
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Comparison of reported sequence of Pfs230
and manual seqyencing data

Reported
Manual

GANAANGANAGG/CANGGT/GANATA!fAT/CCA!ITT/GGT/GAT
GANAANGANAGG/CANGGT/GANATA!TAT/CCA!ITT/GGT/GAT

Reported
Manual

GANGANGANAANGAT/GANGGTIGGNGANAGTrrITIACC/TAT
GANGANGANAANGATIGANGGTIGGNGANAGTrrIT/ACC/TAT

Reported
Manual

GANAAG/AGC/GAG/GTT/GAT/AANACAfGAT/TGTrrIT/AAA!ITT
GANAAG/AGC/GAG/GTT/GAT/AANACAfGAT/TGTrrIT/AAA!ITT

Reported
Manual

ATNGANGGG/GGT/GANGGNGAT/GAT/GTA!fAT/AANGTG/GAT
ATAfGANGGG/GGT/GANGGAfGAT/GAT/GTA!TAT/A_AfGTG/GAT

Reported
Manual

GGT/TCC/AANGTT/TTNTTNGAT/GAT/CAT/ACNATT/AGT/AGA
GGT/TCC/AANGTT/TTNTTNGAT/GAT/CAT/ACNATT/AGT/AGA

Reported
Manual

GTNTCT/AANAANCAT/ACT/GCNCGNGAT/GGT/GAA!TAT/GGT
GTA!TCT/AANAANCAT/ACT/GCNCGNGAT/GGT/GAA!TAT/GGT

Reported
Manual

GAA!TAT/GGT/GANGCT/GTC/GANGAT/GGNGANAAT/GTT/ATA
GAA!TAT/GGT/GANGCT/GTC/GANGAT/GGNGA

Reported

AANATNATT/AGNAGT/GTG/TTNCANAGT/GGT/GCNTTNCCA

Reported

AGT/GTNGGT/GTT/GAT/GAG/TTNGAT/AANATC/GAT/TTG/TCA

Reported

TAT/GANACNACNGANAGT/GGNGATIACT/GCT/GTA!TCC/GAA

Reported

GAT/TCA!TAT/GAT/AANTAT/GCA!TCT

Figure 8. The nucleic acid sequence of Pfs230.C-Nterm was determined and compared
with the reported sequence of Pfs230. The top line represents the nucleic acid sequence of
Pfs230 and the bottom line represents the data obtained from the manual sequencing of CNterm/mYEp.
The underlined nucleotide represents the base not seen on the
autoradiograph obtained by manual sequencing.
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reported sequence. Base pair #149 is one of three sequential A's as reported in Pfs230.
Only two A's were visible on the autoradiograph in that region.

There is, however,

clearly an empty space adjacent to those two A's.

S. cerevisiae Transformation

The first step in obtaining S. cerevisiae that expresses C-Nterm was to transfect S.

cerevisiae with the C-Nterm/mYEp construct S. cerevisiae strain 2095-6 was grown in
YPD media, harvested, washed, and transfected with the Qiagen purified C-Nterm/mYEp
construct as described in Materials and Methods. Electroporated yeast was grown on
SCM minus TRP plates. After three days three colonies were selected and grown in SCM
minus TRP liquid media.

This culture was used to inoculate YPHSM media which

induces protein expression. Protein expression was evaluated 72 hours post inoculation.
Yeast expression cultures were fractionated by centrifugation (5,000 x g) and the
supernatants were harvested. Five hundred µl of supernatant was TCA precipitated and
resuspended in 50 µI lX sample buffer, 5%

~-mercaptoethanol.

Twenty-five µl samples

of the yeast expression media supernatant were electrophoresed on a 12% polyacrylamide
separating gel, 3.75% polyacrylamide stacking gel and protein was detected by Coomassie
blue staining (Figure 9).
On the Coomassie stained gel seen in Figure 9, there were a number of distinct low
molecular weight protein bands (seen in lanes 2-4) associated with C-Nterm/mYEp
transfected yeast supernatant that were not seen in the yeast transfected with YEp alone
(lane 1). When interpolated by molecular weight standards (Amersham, Cleveland, OH)
using linear regression, the unique protein bands on this gel appear to be the following
sizes (major bands are in bold print and underlined):
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1

2

3

4

--30kDa

--21.5 kDa

Figure 9. TCA precipitated supernatant of yeast transfected with C-Nterm/mYEp. Protein
expression was evaluated on a 12 % SDS-polyacrylamide gel. Lane 1 contains the
equivalent of 250 µl YEp transfected yeast supernatant. Lanes 2-4 contain the equivalent
of 250 µl C-Nterm/m YEp transfected yeast supernatant. Amersham molecular weight size
standards are indicated on the right.
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Lane 2: 30.58 kDa, 28.48 kDa, 21.04 kDa, 18.58 kDa, 16.11 kDa;
Lane 3: 30.04 kDa, 27 .98 kDa, 20.31 kDa, 18.25 kDa, 15.83 kDa
Lane 4:

28.48 kDa.

----

The predicted size of recombinant C-Nterm was 16,270 Da.

Western Blot Analysis of Proteins in Yeast Supernatant

A western blot was performed to determine if the protein bands seen in the
supernatant of yeast transfected with C-Ntenn/mYEp were recognized by antibodies
generated to E. coli produced r230.MBP.C (Anti-r230.MBP.C).

Anti-r230.MBP.C

antibodies have been shown to recognize parasite-produced Pfs230 (Williamson et al.,
1995).

TCA precipitated supernatant of yeast transfected with YEp alone and yeast

transfected with C-Ntenn/mYEp were size fractionated on a 15% polyacrylamide
separating gel, 3.75% polyacrylamide stacking gel.

Proteins were electrophoretically

transferred to two nitrocellulose membranes and the membranes were separately incubated
with

antibodies

that

were

generated

against

Pfs230

region

C

(Anti-

r230.MBP .C)(Williamson et al., 1995) and antibodies generated in mice immunized with
MBP alone (Anti-MBP)(Williamson et al., 1995).

The Anti-MBP antibodies were

included as a control because antibodies to region C were generated in mice vaccinated
with recombinant Pfs230 produced in E.coli as fusions with MBP.
Results showed that there were no bands present in the lane corresponding to yeast
transfected with YEp on the Anti-r230.MBP.C blot.

There was reactivity, however,

between the C-Ntenn/mYEp yeast transfected supernatant and Anti-r230.MBP.C (Data not
shown). The C-Ntenn/mYEp protein bands on this blot appeared to migrate in the same
molecular weight range as the C-Ntenn/mYEp transfected yeast supernatant proteins in the
original Coomassie stained gel (Figure 9). No reactivity was seen with YEp transfected
yeast supernatant or C-Ntenn/mYEp transfected yeast supernatant on the Anti-MBP blot
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(Data not shown).

This suggested that there was no irnmuno-crossreactivity between

Anti-MBP and the proteins produced in YEp transfected yeast or C-Nterm/mYEp
transfected yeast.

Ni2+ -NTA Purification of Recombinant C-Nterm Protein

A Ni2+-NTA affinity column, which selectively binds six histidine tagged proteins,
was used to purify recombinant C-Nterm from the C-Nterm/mYEp transfected S .
cerevisiae culture supernatant. C-Nterm/mYEp transfected yeast supernatant was dialyzed

against IX PBS.

Ni2+-NTA resin equilibrated with Column buffer was added to the

dialyzed yeast supernatant and the mixture incubated for one hour on ice.

The

supernatant/resin slurry was loaded onto two columns to increase the flow rate through the
columns. Fractions eluted from the columns were then evaluated for protein by SDSp AGE and western blot analyses.
Aliquots taken throughout the purification were size fractionated on a SDS-PAGE
gel (Figure 10).

Protein bands were interpolated against Sigma molecular weight

standards (Sigma Chemical Company, St. Louis, MO). Both high and low molecular
weight bands were present in the IX PBS-dialyzed C-Nterm/mYEp transfected yeast
supernatant and in the material which was applied to but did not bind to the Ni 2+-NTA
affinity column (lanes I and 2, respectively). The bands in lanes I and 2 were found to
migrateinanearlyidenticalpatternfrom 75.I5 kDa-I8.20 kDa except for the band in the
25 kDa range which was fainter in lane 2.
pH 7.0 wash contained no bands.

Lanes 3-5 which contained fractions from the

Only one eluant (lane 8) from the pH 7.0 Wash

Buffer/irnidazole wash contained protein (Figure 10).

The bands in lane 8 were

interpolated against Sigma molecular weight standards by linear regression and were
found to migrate at: 25.61 kDa, 22.39 kDa, 21.70 kDa, 20.61 kDa, 18. 78 kDa. The
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--66kDa
--45kDa
--34.7kDa

:+----

24 kDa

- - 18.4kDa

Figure 10. Nf+-NTA purification of protein from C-Nterm/mYEp transfected yeast.
Material eluted from the affinity column was size fractionated on a 12% SDSpolyacrylamide gel and stained in Coomassie blue. Lane 1 contains a 20 µl sample of lX
PBS-dialyzed C-Nterm/mYEp transfected yeast supernatant prior to adding the Ni2+-NTA ·
resin. Lane 2 contains 20 µl of material which was applied to but did not bind to the Nf+ NTA affinity column. Lanes 3-5 contain 20 µl of material recovered after the first three
sequential pH 7.0 washes. Lane 6 contains 10 µl Sigma molecular weight standards and
the corresponding sizes are indicated on the right. Lanes 7-10 contain 20 µl fractions of
material eluted from the column after applying pH 7.0 Wash buffer/0.5 M imidazole.
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bands seen in lane 8 were similar in size to the low molecular weight bands seen in the
original C-Nterm/mYEp transfected yeast dialysate (lane 1) and in the material which did
not bind to the affinity column (lane 2). However the higher molecular weight bands. seen
in the dialyzed, unpurified yeast supernatant (lane 1) and in the material which flowed
through the affinity column (lane 2) were not present in lane 8. An elution pattern similar
to the one in Figure 10 was seen on the gel in which protein eluted from the second Ni2+
affinity column was electrophoresed (Data not shown).

Characterization of Purified C-Nterm

1. Western Blot Analyses of Ni2+-NTA Purified Protein. Using antibodies with
different specificities, the Ni2+-NTA purified protein was characterized by western blot
analyses. To determine the immuno-crossreactivity with Pfs230 region C produced in E.

coli, protein eluted from the column was probed with Anti-r230.MBP.C.

Additionally,

monoclonal antibodies against the FLAG polypeptide (Anti-FLAG Ml) (Eastman Kodak
Company, New Haven, CT) were used to determine if the amino terminus of C-Nterm
was present. The DNA sequence which encodes the FLAG peptide is located at the 5' end
of the MCS in mYEp but is downstream of the a signal secretory sequence.

As the

protein moves through the secretory pathway, the a signal sequence is removed, leaving
the FLAG peptide at the amino terminus of C-Nterm. Anti-FLAG Ml only reacts with the
FLAG peptide when it is on the exposed amino terminus of a recombinant protein.
Lastly, protein purified from the Ni 2+ column was also probed with antibodies to MBP
(Anti-MBP) to be sure that reactivity with Anti-r230.MBP.C was specific for r230.C and
not its fusion partner, MBP.

Reactivity of purified C-Nterm with Anti-MBP would call

into question any reactivity seen with Anti-r230.MBP.C.
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As a negative control, the protein pattern and immunoreactivity of supernatant from

yeast transfected with YEp alone was compared with the immunoreactivity of selected
fractions of supernatant from yeast transfected with C-Nterm/mYEp.

A Coomassie

stained gel of this material (Figure 11.A) revealed a number of higher molecular weight
proteins in the YEp transfected yeast that were not visible in the yeast supernatant
transfected with the C-Nterm/mYEp construct. The equivalent of 250 µl TCA precipitated
yeast transfected with YEp alone was loaded in lane 1. Bands were interpolated against
Sigma molecular weight standards by linear regression and were found to migrate between
75.58 kDa and 49.66 kDa. This correlates very well with the pattern of YEp transfected
yeast proteins also seen in Figure 10. There were also less intense bands present in the
41.62 kDa to 24.48 kDa range. In lane 2, only 20 µl of lX PBS-dialyzed supernatant
from yeast transfected with C-Nterm/mYEp was loaded. Lane 3 contained 20 µl of CNterm/mYEp transfected yeast supernatant which was applied to but did not bind to the
affinity column. Lane 4 contained 5 µl of material eluted from the affinity column after
applying imidazole. The amount of protein seen in lane 2, which represents material
which did not bind to the affinity column, was significantly lower than the amount of
protein in lane 4 (Figure 11.A).
Only lanes 2-4 which correspond to C-Nterm/mYEp transfected yeast showed
reactivity with Anti-r230.MBP.C (Figure 11.B). No bands were seen in the negative
control lane (lane 1) which corresponds to the equivalent of 250 µl TCA precipitated yeast
transfected with YEp alone. Reactivity was seen in lane 2 where 20 µl of lX PBSdialyzed supernatant from yeast transfected with C-Nterm/mYEp was loaded. Reactivity
was also seen in lane 3 which contained 20 µl of C-Nterm/mYEp transfected yeast
supernatant that was applied to but did not bind to the affinity column.

Additionally,
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reactivity was observed in lane 4 which contained 5 µl of material eluted from the affinity
column. The protein bands seen in lanes 2-4 migrated in a nearly identical fashion to the
bands in the Coomassie stained gel, Figure 11.A.

These data suggested that Anti-

r230.MBP .C was specific for protein that was only present in yeast transfected with the
C-Nterm/mYEp and that the reacting protein was probably Pfs230.C-Nterm.

It also

suggested that there was no crossreactivity between the Anti-r230.MBP.C antibodies and
secreted yeast proteins.
Similar to the previous blot, only lanes 2-4 which correspond to C-Nterm/mYEp
transfected yeast showed reactivity with Anti-FLAG Ml (Figure 11.C).

The

immunostaining pattern was nearly identical to the pattern seen in the Anti-r230.MBP.C
blot (Figure 11.B) and Coomassie stained gel (Figure 11.A) . No bands were seen in the
negative control lane (lane 1) which corresponds to the equivalent of 250 µl TCA
precipitated supernatant from yeast transfected with YEp alone. Because Anti-FLAG Ml
only reacts with the FLAG peptide when it is exposed at the amino terminus of a protein,
this suggested that the FLAG peptide was present on the amino terminus of recombinant
Pfs230.C-Nterm.

Additionally, all of the bands that reacted with Anti-r230.MBP.C

reacted with Anti-FLAG Ml (Figures 11.B and 11.C).

The protein bands in the

Coomassie stained gel as well as the two immunoblots seen in Figure 11.A,B,C were
found to migrate (by extrapolation using linear regression) between 30.83 kDa to 16.09
kDa.
To assay reactivity of purified C-Nterm with Anti-MBP, protein eluted from the
Ni2+ affinity column was electrophoresed on a 15% polyacrylamide separating gel, 3.75%
polyacrylamide stacking gel. A 15% gel was used in order to better visualize the lower
molecular weight bands associated with C-Nterm and determine how they correlate with
bands on a 12% denaturing gel. Part of a 15% gel was Coomassie stained while the other
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1

2

3

4

1

2

3

4

-97 kDa
--69 kDa
-46 kDa

-30 kDa

-22 kDa

Panel A

Panel B

Panel C

Fi&ure 11.A.B.C. Coomassie stammg and immunoblot analyses of purified and
unpurified proteins. On a 12% SDS-polyacrylamide gel, samples of YEp transfected yeast
supernatant as well as unpurified and purified samples from C-Nterm/m YEp transfected
yeast supernatant were electrophoresed. Proteins in panel A were stained by Coomassie
blue. Proteins in panel B were electrophoretically transferred to nitrocellulose and probed
with Anti-r230.MBP.C. Proteins in panel C were electrophoretically transferred to
nitrocellulose and probed with Anti-FLAG Ml. Lane 1 in all three panels contained the
equivalent of 250 µl YEp transfected yeast supernatant. Lane 2 in all three panels
contained 20 µl of IX PBS dialyzed C-Nterm/mYEp transfected yeast supernatant before
it was purified. Lane 3 in all three panels contained 20 µl material which was applied to
but did not bind to the affinity column. Lane 4 in all three panels contains 5 µl of protein
eluted from the Ni2+-NTA affinity column. Molecular weight standards are seen on the left
in panels B and C and the corresponding sizes for all panels are indicated on the far iight.
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part was electrophoretically transferred to nitrocellulose and probed with Anti-MBP. The
Coomassie stained gel showed several bands associated with the C-Nterm eluant and those
bands were interpolated against Amersham molecular weight standards as well as Sigma
molecular weight standards (Figure 12). In contrast to the Sigma standards, Amersham
standards are pre-stained and are therefore a less accurate reflection of size than are the
Sigma standards. The covalent attachment of dyes to the proteins causes the Amersham
standards to migrate more slowly than their true molecular weight (Amersham
Corporation, 1996). As seen in Figure 12, the sizes of C-Nterm bands interpolated by
Amersham standards and Sigma standards using linear regression ranged as follows:
Amersham standards

Sigma standards

28.46kDa

26.22kDa

26.94kDa

25.06kDa

24.13 kDa

22.88 kDa

21.62 kDa

20.90kDa

19.91 kDa

19.52kDa

19.36kDa

19.0SkDa

17.83kDa

17.83kDa

16.42kDa

16.65kDa

15.12kDa

15.56kDa

No reactivity was seen with C-Nterm on the Anti-MBP western blot (Data not shown)
suggesting that Anti-r230.MBP.C is truly recognizing C-Nterm and not MBP.

2. Glycoprotein Detection. Because Pfs230.C-Nterm appeared to be a higher molecular
weight than the calculated 16,270 kDa, it was necessary to consider if the protein had been
posttranslationally modified.

A common posttranslational modification of proteins

expressed and secreted by yeast is glycosylation.

To test for the presence of

carbohydrates on C-Nterm, protein samples were electrophoretically transferred to

62

2

3

69kDa

66kDa

46kDa

45kDa
34.7 kDa

30kDa
24kDa
21.5 kDa
18.4 kDa
14.3 kDa

14.3 kDa

Fi&ure 12. Electrophoretic analysis of purified C-Nterm on a 15% SDS-polyacrylamide
gel. Purified C-Nterm was size fractionated on a 15% SDS-polyacrylamide gel and its
size interpolated against Amersham and Sigma molecular weight markers. Lane 1 contains
Amersham molecular weight standards and the sizes are indicated on the left. Lane 2
contains 3 µl of Ni 2+ purified C-Nterm. Lane 3 contains Sigma molecular weight
standards and the corresponding sizes are indicated on the right.
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nitrocellulose.

For comparison, IX PBS-dialyzed yeast supernatant from yeast

transfected with C-Nterrn/mYEp was loaded in lane 1 while an aliquot of material which
did not bind to the Ni 2+-NTA affinity column was loaded in lane 3. Glycoproteins _were
detected using the Glycan Detection Kit (Boehringer Mannheim, Indianapolis, IN)
described in the Materials and Methods. As seen in Figure 13 there are several high
molecular weight bands which showed a very similar pattern of reactivity in both lanes.
The bands in lane 1 were interpolated against Amersham molecular weight standards by
linear regression and were found to migrate between 97.51 kDa and 41.35 kDa (Figure
13). The bands in lane 3 migrated between 97.51 kDa and 42.73 kDa (Figure 13). No
bands in the 28 kDa-16 kDa range (apparent weight of C-Nterm as interpolated by
Amersham standards) showed reactivity (Figure 13).

C-Nterm Protein Sequencinf:

Because the eluted protein was estimated to be 10 kDa larger than the theoretical
weight, the possibility that the amino acid sequence of the protein had been altered,
perhaps by a mutation or rearrangement in the DNA, was considered. The major (highest
molecular weight) C-Nterm band was purified using HPLC and was then subjected to
Staphylococcus aureus (V8) protease digestion. Peptides were purified by HPLC using a

C4 reversed phase column (Dr. Bassam Wakim, PhD). A peptide 10 amino acids in
length and a peptide 17 amino acids in length were sequenced (Figure 14) and found to be
identical with the reported sequence of Pfs230.C-Nterm (amino acid 8 to amino acid 17
and amino acid 42 to amino acid 58, respectively)(Figure 14).

C-Nterm DNA Sequencinf:

Although the amino acid sequence of the peptides obtained from C-Nterm were
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Figure 13 . Glycoprotein analysis of C-Nterm/mYEp transfected yeast supernatant.
Proteins were size fractionated on a 12% SDS-polyacrylamide gel, electrophoretically
transferred to a nitrocellulose membrane, and assayed for the presence of carbohydrate
moieties. Lane 1 contains 20 µl of IX PBS dialyzed C-Nterm/mYEp transfected yeast
supernatant. Lane 2 contains Amersham molecular weight standards and corresponding
sizes are indicated on the right. Lane 3 contains 20 µl of C-Nterm/m YEp transfected yeast
material that was applied but did not bind to the Ni 2+-NTA affinity column.
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Amino acid sequence of
Pfs230.C-Nterm

Reported

EK ER QG EI YP FG DEEEK DEG G ES F TYEK SE V

Reported

DK TDLFKFIEG G EG DDVYK VDG SK VIL DD D TIS

Reported

RV S K K HT ARD GEY G EA V ED GEN V I K I I R S V L Q S

Reported

GALP S VG VD ELD KID L S YETT E S G D TA V S ED S Y D

Reported

KY A S

Fi~ure

14. Peptide sequencing data of yeast expressed Pfs230.C-Nterm. This schematic
illustrates the reported amino acid sequence of Pfs230.C-Nterm and the two peptides
obtained from protein sequencing are underlined. The bolded, lower case amino acid
(#57) obtained in the peptide sequence represents the questionable region of substitution in
yC-Nterm/mYEp DNA sequencing data (see Figure 16).
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correct, there was still the possibility that the DNA sequence of C-Nterm had been altered
downstream of amino acid 58 and had disrupted the stop codons, resulting in a larger
protein. This could have been caused by a mutation in the stop codons themselves. or a
change in the reading frame upstream from the stop codons. To determine if yeast had
rearranged the plasmid, the C-Nterm/mYEp construct was recovered. The first step in
harvesting the construct from yeast involved spheroplasting the yeast using lyticase. Two
tests were used to determine if the spheroplasting was successful: 1) precipitate formation
in 1Msorbitol2) lysis in 2% SDS. These experiments suggested that the yeast cell wall
had been removed making the yeast sensitive to detergent lysis. Proteinase K was then
added to the spheroplasts and a phenol extraction was performed to remove protein. The
DNA was further purified by a chloroform extraction and was used to transfect E. coli.
To select for ampicillin resistance, transfected bacteria was plated onto LB/agar plates
containing ampicillin. Only colonies which contained mYEp vector should be resistant to
ampicillin and therefore able to survive.

Both the pUC19 control plate and the

experimental plates were confluent therefore transformation efficiency was not determined.
Plasmid purified from amplified yC-Nterm/mYEp colonies was compared with the
original construct C-Nterm/mYEp (construct before it was transfected into yeast) by
restriction analysis using Kpn I and Spe I. A Kpn I site is 44 base pairs upstream of the
C-Nterm inse11 in the mYEp vector. A Spe I site is 494 base pairs downstream of the CNterm insert.

A digest with Kpn I and Spe I of both C-Nterm/mYEp and yC-

Nterm/mYEp resulted in two fragments on a 1.0% agaroseffAE gel (Figure 15). The
sizes of these bands were interpolated against size standards by linear regression. The
bands for yC-Nterm/mYEp were found to migrate at: a band at 7.95 kB base pairs
(mYEp); a second band at 813 base pairs (the approximate size of the insert (414 base
pairs) plus the additional mYEp vector sequence (574 base pairs)). The sizes of the CNterm/mYEp bands interpolated as follows: a band at 8.10 kB and a band at 813 base
pairs. Thus the size of the mYEp and C-Nterm fragments were the same both before and
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1

2

3

-23.lkB
9.4kB
6.6kB

-1.3kB
-1.lkB
-.872kB

Figure 15. Restriction digests of yC-Nterm/mYEp and C-Nterm/mYEp. To compare to
size of the inserts, yC-Nterm/mYEp and C-Nterm/mYEp were digested with Kpn I and
Spe I (enzymes flanking the C-Nterm insert). These digests were size fractionated on a
1% agaroseffAE gel. Lane 1 contains DNA size standards with the corresponding sizes
indicated on the right. Lane 2 contains 25 µl of the yC-Nterm/m YEp digest. Lane 3
contains 10 µl of the C-Nterm/mYEp digest.
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after transfection into yeast. This suggests that the yeast made no major rearrangements
that altered the size of the plasmid.

Automated DNA Sequencini:

The results of the restriction endonuclease digestion of yC-Nterm/m YEp showed a
pattern of bands consistent with the size of the vector (7 .2 kB) and the size of the insert
(414 base pairs). However, the reading frame of yC-Nterm/mYEp DNA still could have
altered by a single base deletion or insertion that would not cause a dramatic change in the
size of the mYEp and C-Nterm fragments on an agaroseffAE gel.

Thus, to further

determine if the yC-Nterm/mYEp construct had been altered by the yeast, 0.3 µg/µl of
Qiagen purified yC-Nterm/mYEp was sent to the University of Chicago, Chicago, IL for
automated sequencing. The construct was sequenced from both the 5' end and the 3' end
using 0.8 pmol/µl of the YaN-21 sense primer and YcC-21 antisense primer, respectively
(Eastman Kodak Company, New Haven, CT).

These primers correspond to sequence in

mYEp. The resulting chromatogram was read (Figure 16) and compared with the known
sequence Pfs230.C-Nterm (Figure 16).
The chromatogram generated using primer YaN-21 (corresponding to vector base
pairs #1388-#1408) was read beginning at vector base pair #1412, which is in the FLAG
sequence of mYEp (Figure 16). The chromatogram was read up to and including vector
base pair #1567, which is 3' to the six histidine tag and the two stop codons in the mYEp
vector. Pfs230.C-Nterm was inserted into the vector in between base pair #1502 and base
pair #1537.
The chromatogram generated using primer YcC-21 (corresponding to vector base
pairs #1633-#1613) was read beginning at vector base pair #1582, which is in the CYCl
part of the mYEp vector (Figure 16). The chromatogram was read up to and including
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Sequencing Pfs230.C-Nterm

Reported
Automated
Manual
Protein

tt/ata/aat/act/act/att/gcc/agc/att/gct/gct/aaa/gaa/gaa/ggg/gta/cct/ttg/gat/aaa/aga/gac/tac/aag
tt/ata/aat/act/act/att/gcc/agc/att/gct/gct/aaa/gaa/gaa/ggg/gta/cct/ttg/gat/aaa/aga/gac/tac/aag

Reported
Automated
Manual
Protein

gat/gac/gat/gac/aag/gaa/ttc/ctc/gag/GAA/AAAIGAA/AGG/CAA/GGT/GAA/ATA/TAT
gat/gac/gat/gac/aag/gaa/ttc/ctc/gag/GAA/AAA/GAA/AGG/CAA/GGT/GAA/ATA/TAT
GAAi AAA/GAAiAGG/CAA/GGT/GAA/ AT A/TAT
E
K
E
R
Q
G
E
~

Reported
Automated
Manual
Protein

CCA/TTT/GGT/GAT/GAA/GAA/GAA/AAA/GAT/GAA/GGT/GGA/GAA/AGT/TTT
CCA/TTT/GGT/GAT/GAA/GAA/GAA/AAA/GAT/GAA/GGT/GGA/GAA/AGT/TTT
CCA/TTT/GGT/GAT/GAA/GAA/GAA/AAA/GAT/GAA/GGT/GGA/GAA/AGT/TTT
P F
G
D E
E
E
K
D
E
G
G
E
S F

Reported
Automated
Manual
Protein

ACC/TAT/GAA/AAG/AGC/GAG/GTT/GAT/AAA/ACA/GATITTG/TTT/AAA/TTT
ACC/TAT/GAA/AAG/AGC/GAG/GTT/GAT/AAA/ACA/GATITTG/TTT/AAA/TTT
ACC/TAT/GAA/AAG/AGC/GAG/GTT/GAT/AAA/ACA/GATITTG/TTT/AAA/TTT
T
Y E
K
S
E
V
D
K
T D
L
F
K F

Reported
Automated
Manual
Protein

ATA/GAA/GGG/GGT/GAA/GGA/GAT/GAT/GTA/TAT/AAA/GTG/GAT/GGT/TCC
AT A/GAA/GGG/GGT/GAA/GGA/GAT/GAT/GTA/TAT/AAA/GTG/GAT/GGT/TCC
ATA/GAA/GGG/GGT/GAA/GGA/GAT/GAT/GTA/TAT/A_A/GTG/GAT/GGT/TCC
I
E
G G
E
G
D D
V
Y K V
D G S

Reported
Automated
Manual
Protein

AAA/GTT/TTA/TTA/GAT/GAT/GAT/ACA/ATT/AGT/AGA/GTA/TCT/AAA/AAA
AAA/GTT/TCA/TTA/GAT/GAT/GAT/ACA/ATT/AGT/AGA/GTA/TCT/AAA/AAA
AAA/GTT/TTA/TTA/GAT/GAT/GAT/ACA/ATT/AGT/AGA/GTA/TCT/AAA/AAA
K V L
L
D D D
T
I
S
R
V S
K K

Reported
Automated
Manual
Protein

CAT/ACT/GCA/CGA/GAT/GGT/GAA/TAT/GGT/GAA/TAT/GGT/GAA/GCT/GTC
CAT/ACT/GCA/CGA/GAT/GGT/GAA/TAT/GGT/GAA/TAT/GGT/GAA/GCT/GTC
CAT/ACT/GCA/CGA/GAT/GGT/GAA/TAT/GGT/GAA/TAT/GGT/GAA/GCT/GTC
H
T A
R
D G
E
Y G
E
Y G
E
A
V

Figure 16. DNA sequence of yC-Nterm/mYEp. The top line of the schematic represents
the reported sequence of Pfs230 and mYEp. The second line reports the data obtained
from automated sequencing of yC-Nterm/mYEp. The third line shows the sequence read
from the autoradiograph of manually sequenced C-Nterm/mYEp. Vector sequence is in
lower case letters and Pfs230 sequence in upper case. Underlined, bolded nucleotides
indicate discrepancies between that sequence and the reported sequence of Pfs230. Stop
codons in the vector as well as the six histidine tag are noted. Figure continues on page
70.
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Sequencing Pfs230.C-Nterm

Reported
Automated
Manual
Protein

GANGATIGGNGANAAT/GTf/ATNAANATNATf/AGNAGTIGTG/TINCAA
GANGATIGGNGANAATIGTf/ATNAANATNATf/AGNAGT/GTG/TINCAA
GANGATIGGNGA
EDGE
NV
I
KI
IRS
V L
Q

Reported
Automated

AGT/GGT/GCNTINCCNAGT/GTNGGT/GTI/GAT/GAG/TTNGAT/AANATC

AGT/GGTIGCNTTNCCNAGTIGTNGGT/GTI/GAT/GGGITINGAT/AANATC

Manual

Protein
Reported
Automated

S

G

A

L

P

S

V

GVD

ELD

KI

GATITIGITCA/TAT/GANACNACNGANAGT/GGNGATIACT/GCTIGTAITCC
GATITIGITCA/TAT/GANACNACNGANAGT/GGNGAT/ACT/GCT/GTA/TCC

Manual

Protein

D

L

S

Y

E

T

TES

GD

T

AV

S

6 his tag
Reported
Automated

GANGAT/TCA/TAT/GAT/AANTAT/GCA/TCT/ggg/ccc/gtc/gac/cac/cac/cac/cac/cac
GANG~T/TCA/TAT/GAT/AANTAT/GCA/TCT/ggg/ccc/gtc/gac/cac/cac/cac/cac/cac

Manual

Protein

E

D

Stop
Reported
Automated

SYD

KY

AS

Stop

cac/tag/gct/agc/ccg/taa/gcg/gcc/gct/gat/ccg
cac/tag/gct/agc/ccg/taa/gcg/gcc/gct/gat/ccg

Manual

Protein

Fi~ure 16 (continued from pa~e 69). DNA sequence of yC-Nterm/mYEp. The top line of
the schematic represents the reported sequence of Pfs230 and mYEp. The second line
reports the data obtained from automated sequencing of yC-Ntenn/mYEp. The third line
shows the sequence read from the autoradiograph of manually sequenced C-Ntenn/mYEp.
Vector sequence is in lower case letters and Pfs230 sequence in upper case. Underlined,
bolded nucleotides indicate discrepancies between that sequence and the reported sequence
of Pfs230. Stop codons in the vector as well as the six histidine tag are noted.
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vector base pair #1343, which is in the a signal secretory sequence of the mYEp vector
(Figure 16).
Thus the entire Pfs230.C-Nterm insert sequence and several base pairs before and
after were sequenced in both directions. Three discrepancies were found between the
chromatogram for these runs and the reported sequence of the Pfs230.

The first

discrepancy was noted at insert base pair #170, where there was a C instead of the
predicted base pair, T (Figure 16). In contrast, data for the protein sequence of C-Nterm,
corresponding to base pair #170 of C-Nterm, read as predicted by the reported sequence
of Pfs230 (Figure 16). The second discrepancy was found at insert base pair #329, where
there was a G instead of the predicted base pair, A (Figure 16). Lastly, insert base pair
#392 should have been an A instead of the G seen in the chromatogram (Figure 16). Base
pair #392 was actually part of the synthetic primer used in the PCR.
To summarize, the sequencing runs using the YaN-21 and the YcC-21 primers
overlapped for much of the mYEp vector and for all of the C-Nterm insert. Sequencing
from both directions indicated differences between the automated sequence and the
reported sequence of Pfs230 in the same three base pairs. No deletions or insertions were
identified in the stop codons suggesting that the reading frame had not been altered.

CHAPTER IV

DISCUSSION

In previous studies Pfs230 was expressed as six separate MBP fusion proteins in
E. coli (Williamson et al., 1995). Results from mice vaccinations with one of those six

recombinants, r230/MBP.C, suggested this region may be a possible transmissionblocking vaccine candidate. In mosquitoes fed on antisera generated to r230/MBP.C
parasite infectivity was reduced 71.2-89.8% (Williamson et al., 1995).

While 71.2-

89.8% reduction in parasite infectivity is impressive, an effective transmission-blocking
vaccine must reduce infectivity completely. One possible explanation why r230/MBP.C
failed to reduce parasite infectivity in the mosquito midgut entirely may be that the
recombinant protein did not fold properly in the E. coli cytosol, a reduced environment.
Previous studies have determined that Pfs230-specific monoclonal antibodies require
proper protein conformation in order to rec·ognize antigens and that these monoclonal
antibodies are reduction sensitive (Read et al., 1994).
Possibly the most important aspect in developing a vaccine is that a synthetic
antigen accurately mimics the native antigen structure.

A previous study with P.

falciparum protein Ffs25 showed that a yeast expression system produced a potent antigen

which induced transmission-blocking while E.coli did not (Kaslow and Shiloach, 1994).
Being a eukaryote, proteins expressed in yeast can be targeted to an extensive secretory
pathway which allows the protein to be generated in a non-reduced environment.

A

crucial element in this secretory pathway is the rough endoplasmic reticulum (absent in E.
coli) which contains proteins specifically involved in the regulation of folding (i.e.

chaperones, isomerases). Therefore synthesis of recombinant polypeptides via a yeast
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expression system may generate a more accurate representation of parasite-produced
Pfs230 than an E. coli expression system.
The objective of this study was to produce a small part of Pfs230 region C, CNterm (amino acid 447 to amino acid 584), using a yeast expression system. Yeast Nterminal Flag Expression System (YEp) was chosen as the vector. YEp encodes a two
micron circle and a tryptophan selectable marker for growth and selection in yeast. Protein
expression in yeast transfected with the YEp vector is regulated by the alcohol
dehydrogenase promoter (ADH2). ADH2 is a strong yeast promoter capable of directing
extremely high intracellular levels of (foreign) protein expression.

This could be a

problem if the recombinant, foreign protein is toxic to the yeast (fuite and Oliver, 1991).
To alleviate this, the ADH2 promoter is repressed in the presence of glucose while initial
yeast cell growth occurs. Once the yeast have metabolized the glucose the ADH2 promoter
is derepressed to a high level and protein expression begins. YEp vector also encodes an

a leader sequence which targets the ribosome to the rough endoplasmic reticulum
membrane.

After translocation across the rough endoplasmic reticulum, the signal

sequence is cleaved by a membrane bound protease.

This cleavage leaves the

immunogenic FLAG peptide on the exposed amino terminus of the recombinant protein.
YEp was modified to mYEp by adding a Nhe I restriction site and six histidines at
the 3' end of the MCS using a synthetic oligonucleotide. The addition of the six histidines
to the carboxy terminus of recombinant yeast-expressed C-Nterm protein provided the
option of purifying the recombinant protein with a Nf+-NTA column. Proteins with six
histidines at either the amino or carboxy terminus bind to a Nf+-NTA affinity column with
a greater affinity than most antibodies and antigens (Qiagen Inc., 1992).

The FLAG

peptide at the amino terminus of C-Nterm could also be used to purify the recombinant
using a Anti-FLAG Ml affinity column. Together the FLAG and six histidines could be
used as indicators to determine if full length protein was present. The modified vector
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(mYEp) is 7.2 kB and was distinguished on an agaroseffAE gel from unmodified YEp by
a restriction endonuclease digestion with Nhe I, a site unique to mYEp.
Using the modified vector, the C-Nterm/mYEp construct was developed. . CNterm was PCR amplified using oligonucleotide primers corresponding to base pair
#1339 to base pair #1752 (encoding amino acid 447 to amino acid 584) in Pfs230.

C-

Nterm was then digested with Xho I and Apa I restriction enzymes and ligated into the
corresponding sites in mYEp. Transformation efficiency was calculated as a measure of
quality control for future ligations. The 1.5 x 109 CFU transformation efficiency of
pUC19 indicated that the technique was performed correctly. The efficiency for the CNterm/mYEp ligation mix (2.56 x 104 CFU) was low compared to the controls but this
was expected since the control plasmid was supercoiled. The presence of the C-Nterm
insert in mYEp was confirmed by restriction analysis using Kpn I and Spe I.

Results

showed two bands on an agaroseffAE gel which were by molecular size standards using
linear regression and found to be 7 .95 kB and 931 base pairs. These are the approximate
sizes of mYEp and C-Nterm plus vector sequence, respectively, and thus the presence of
these bands indicated that the construct had been produced.
Manual sequencing confirmed that C-Nterm/mYEp was produced and more
importantly that C-Nterm/mYEp was in the proper reading frame. Sequence was obtained
starting with 15 base pairs of the vector (corresponding to vector base pair #1493 to base
pair #1507). These base pairs were read and found to correlate with the actual sequence of
mYEp (Figure 7). The vector sequence ended at the Xho I restriction site (base pair # 1502
to base pair #1507) and the sequence corresponding to Pfs230 started. This indicated that
C-Nterm was ligated into mYEp at the intended site and that the reading frame was
maintained. For Pfs230.C-Nterm, base pair #1 to base pair #263 of the 404 base pair
C-Nterm were readable on the autoradiograph. Within that sequence only one mismatch
with the predicted sequence of Pfs230 was found. Base pair #149, which should have
been nucleotide A, was not seen on the autoradiograph. All other nucleotides read from
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the autoradiograph conformed to the reported sequence of Pfs230.C-Nterm.

Base pairs

#148 and #150 (like base pair #149) are also A's and there is a visible gap between them
on the autoradiograph indicating that a base was probably present but no ddATP_ was
incorporated.

If, however, this base pair was missing, the reading frame of C-

Nterm/mYEp downstream to base pair #149 would have been altered.

This seems

unlikely because base pair #149 was identified later in automated sequencing of yCNterm/mYEp, to which C-Nterm/mYEp was a predecessor. Additionally, amino acid 50
which is encoded by base pairs #148-#150 was a lysine on the peptide sequencing data.
This conforms with the reported sequence of Pfs230.

Furthermore, a pattern on the

autoradiograph near the 3' end of the template appeared to be several consecutive GTC
codons.

The GTC codon encodes the amino acid histidine.

This region probably

corresponds to the six histidine tag encoded at the 3' end of the multiple cloning site in
mYEp and suggested that the full length C-Nterm/mYEp DNA was present.
Since the restriction digest and sequencing results confirmed that the construct had
been produced, the next stage of the project involved transfecting yeast with CNterm/m YEp.

Yeast was transfected with C-Nterm/mYEp, grown on SCM minus

tryptophan/agar plates, resultant colonies were selected and then amplified further in SCM
minus tryptophan liquid culture. Protein expression was induced in YPHSM expression
media which contained a fixed amount of glucose, the preferential energy source of yeast.
Once glucose is depleted by yeast metabolism (-24 hours) the yeast alcohol
dehydrogenase promoter (ADH2) is derepressed and protein expression begins. TCAprecipitated aliquots of C-Nterm/mYEp transfected yeast supernatant were loaded on a
SDS-polyacrylamide gel to evaluate protein expression. As reported in the results and as
seen in Figure 9, there were several bands between 30 kDa-16 kDa (with a major band at
28 kDa +/- 0.5 kDa) when interpolated by Amersham standards.

These bands were

present in the lanes (2-4) which contained C-Nterm/mYEp transfected yeast supernatant
and were absent in the yeast transfected with YEp vector alone (lane 1). This suggests that
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these unique bands correspond to C-Nterm. Many higher molecular weight proteins were
present in all four lanes (including lane 1), but these were not as visible as the lower
molecular weight bands and did not reproduce well in the photograph. The theoretical size
of C-Nterm is 16,270 Da.
Samples of yeast supernatant transfected with YEp alone and yeast transfected with
C-Nterm/mYEp were electrophoretically blotted onto nitrocellulose and probed with Antir230.MBP.C antibodies and Anti-MBP antibodies. In the Anti-r230.MBP.C immunoblot,
no reactivity was seen in the lane which contained YEp transfected yeast supernatant.
Several bands were present, however, in the lane which contained C-Nterm/mYEp
transfected yeast supernatant and were interpolated to migrate at 26.39 kDa, 23.31 kDa
and 19.35 kDa. These values are bracketed by the same molecular weight range seen in
the original Coomassie gel on which C-Nterm/mYEp transfected supernatant was
electrophoresed (Figure 9). The reactivity of bands unique to C-Nterm/mYEp transfected
yeast supernatant with Anti-r230.MBP.C antibodies strengthened the suggestion that CNterm was being expressed.
As a control, YEp transfected yeast supernatant and C-Nterm/mYEp transfected

yeast supernatant were probed with Anti-MBP antibodies and no reactivity was seen.
Taken together, the Anti-r230.MBP.C and Anti-MBP immunoblots indicated that the
reactivity of Anti-r230.MBP.C with C-Nterm/mYEp transfected yeast proteins was not
due to immuno-crossreactivity of the proteins with antibodies to MBP.

This strongly

suggests that the protein recognized by Anti-r230.MBP.C has amino acid homology to
Pfs230.C, as would C-Nterm.
Ni2+-NTA purification was used to isolate full length C-Nterm from the transfected
yeast supernatant. As mentioned previously, the Ni2+-NTA column binds proteins with
six consecutive histidines. While this sequence rarely occurs in nature, it is present at the
carboxy terminus of full length C-Nterm. After washing the column to remove impurities,
0.5 M imidazole was applied to elute the protein bound to the column (Figure 10). The
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sizes of the eluted protein bands were interpolated against Sigma molecular weight
standards by linear regression.

Protein bands present in samples of C-Nterm/mYEp

transfected yeast dialysate and in material that did not bind to the affinity column were
compared with protein bands in the eluant. In the eluted fraction, there were distinct
protein bands between 25 kDa and 18 kDa, with the bands at 25.61 kDa and 18.78 kDa
being the most intensely stained. Similar bands (25 kDa-18 kDa) were seen in the CNterm/m YEp transfected yeast supernatant dialysate and were also seen, though noticeably
less intense, in the C-Nterm/mYEp transfected yeast supernatant which flowed off the
column. Higher molecular weight proteins (75 kDa to about 42 kDa) present in CNterm/mYEp transfected yeast dialysate and the material which flowed through the column
were not present in the eluted fractions. This data further suggests that the high molecular
weight bands which did not bind to the Ni2+ affinity column represent yeast proteins.
These data indicated that the same size proteins eluted from the column (25 kDa-18 kDa)
were present in the initial C-Nterm/mYEp transfected yeast supernatant and that some of
the C-Nterm protein in the C-Nterm/mYEp transfected yeast supernatant did not bind to
the affinity column.
Protein eluted from the Ni2+-NTA column was electrophoresed on a 15% gel and
stained with Coomassie. This experiment was done to better evaluate the size of the lower
molecular weight bands associated with C-Nterm. The bands were interpolated against
Amersham and Sigma molecular weight standards to determine if there was a difference in
size when using different standards. As mentioned in the results, the Sigma standards are
not pre-stained and therefore provide a more accurate weight of C-Nterm. The size of CNterm using Sigma standards ranged between 26 kDa-16 kDa whereas Amersham
standards reported a range of 28 kDa-15 kDa. One interesting observation noted on other
gels and confirmed on this higher percentage gel was that C-Nterm does not run below 15
kDa-16 kDa (close to its reported size of 16,270 Da). This may suggest that the multiple

78
bands associated with C-Nterm represent an unmodified form (15 kDa-16 kDa) as well as
posttranslationally modified forms (>16, 270 kDa).
To characterize the identity of the eluted protein, immunoblots with _Antir230.MBP .C, Anti-FLAG Ml, and Anti-MBP were performed (Figures 13 and 14 and
data not shown, respectively). The Ni2+ purified protein probed with Anti-MBP showed
no reactivity. Ni2+ purified protein was recognized, however, by both antibodies generated
against Pfs230 region C and the antibodies to the amino terminal FLAG peptide encoded
by mYEp. These results suggested that all the bands present in the C-Nterm/mYEp
transfected yeast supernatant contained amino acids corresponding to Pfs230 region C and
that the FLAG peptide was present at the amino terminus of each. The Anti-MBP blot
suggested that the reactivity between C-Nterm and Anti-r230.MBP.C is not due to
irnmuno-crossreactivity of the recombinant with Anti-MBP antibodies.
Additionally, YEp transfected yeast supernatant was blotted then probed with Antir230.MBP.C, Anti-FLAG Ml and Anti-MBP antibodies as a negative control. The high
molecular weight bands associated with YEp transfected yeast in other gels (Figure 10),
which probably represent endogenous yeast secreted proteins, showed no reactivity with
these antibodies. This indicated that YEp transfected yeast proteins showed no irnmunocrossreactivity with Anti-r230.MBP.C, Anti-FLAG Ml and Anti-MBP.
In summary, the purification of C-Nterm protein by way of Ni2+-NTA indicated
that the carboxy terminus was present because purification required the presence of the six
consecutive histidines on the carboxy terminus of C-Nterm. The reactivity of purified
protein with Anti-r230.MBP.C and Anti-FLAG Ml indicated that the eluted protein
contained amino acids corresponding to Pfs230 and that the amino terminal FLAG of CNterm was present. Together, these data indicated that full length C-Nterm protein was
expressed.
This raises the question of why there are so many bands observed by SDS-PAGE.
Several possible reasons, such as improper folding, mutations in the coding sequence, and
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posttranslational modification, were considered.

The possibility of disulfide bonds

between cysteines causing non-linear migration on the SDS-PAGE gel could be ruled out
immediately because there are no cysteines in Pfs230.C-Nterm. Heterogeneous folding of
C-Nterm was also unlikely on the basis that the protein was evaluated on a SDS
denaturing gel and distinct bands (in opposed to aggregate protein smears) were observed.
Other possibilities considered for the large size of C-Nterm were base pair
substitutions, deletions, or mutations. The C-Nterm/mYEp construct transfected into E.
coli was manually sequenced. The first 263 base pairs of C-Nterm were read and found to
match the reported sequence of Pfs230 with the exception of base pair #149. While this
base pair was not seen on the autoradiograph it was confirmed to have been present by
subsequent peptide and automated DNA sequencing. The possibility that the yeast had
caused mutations in the protein sequence that would result in a dramatic size shift of CNterm was next considered.

Two peptides obtained from a Staphylococcus aureus

digestion of the highest molecular weight C-Nterm band showed perfect sequence
homology with amino acid 8 to amino acid 17 and amino acid 42 to amino acid 58 of the
reported sequence of Pfs230.C-Nterm. This suggests that no mutations that could be
responsible for a dramatic size shift in C-Nterm had occured in the first 58 amino acids of
the protein. However, this did not rule out the possibility of mutations downstream of
amino acid 58. Immunoblot analyses of protein isolated from C-Nterm/mYEp transfected
yeast showed positive reaction when probed with antibodies which recognize Pfs230
region C. Thus, the possibility of mutations present in the first 58 amino acids of the
construct was probably not the explanation for the various sizes associated with C-Nterm.
To determine if the yeast had caused DNA base pair substitutions, deletions, or
mutations which resulted in a size shift of the protein, the C-Nterm/mYEp DNA
transfected into yeast was reharvested and the resultant yC-Nterm/mYEp construct was
digested with restriction enzymes, Kpn I and Spe I. The size of the insert recovered from
yC-Nterm/mYEp after the digest was compared with the size of the insert present in the
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original C-Ntenn/mYEp and the bands (as interpolated against DNA size standards) were
confirmed to be the same size. This suggests that the yeast did not drastically rearrange CNterm to cause a size shift.

To be absolutely certain, however, that no

~najor

rearrangement had taken place in the yeast, the yC-Ntenn/mYEp construct was sent for
automated sequencing. As indicated by accurate peptide sequence and purification by a
Ni2+affinity column, mutations, had they occured, would have had to occur in the center
of C-Nterm, thus restoring the reading frame for the stop codons and the six histidine tag.
Plasmid DNA was isolated from C-Ntenn/mYEp transfected yeast and was used to
transfect E. coli. Ampicillin resistant E. coli was selected and purified plasmid was then
sent to the University of Chicago Sequencing Facility for automated sequencing. The
entire Pfs230 insert and the adjacent vector regions were sequenced from both directions.
This included the region of the mYEp vector in the 3' end of the insert that encoded two

stop codons as well as the base pairs which encoded the Nhe I restriction site and the six
histidine tag. All but three of the nucleotides in the yC-Ntenn/m YEp construct conformed
to the reported sequence of Pfs230.C-Nterm. However, because the two stop codons
present at the 3' end of C-Nterm remained intact it is unlikely that vector sequence was
translated into protein, thus causing a larger protein. This hypothesis is also unlikely on
the basis that the C-Nterm protein would not have been purified if any sequence existed
downstream of the six histidine tag. The six histidine tag must be on the exposed amino
or carboxy terminus to bind to the Ni2+-NTA affinity column (Qiagen Inc., 1992). Clearly
the DNA sequence showed that no major rearrangements occured that dramatically altered
the size of C-Nterm.
The three substitutions that occured in automated sequencing of Pfs230.C-Nterm
were present in the sequencing data from both the 5' and 3' direction.

While these

substitutions were probably not responsible for a 10 k:Da size shift of C-Nterm, they may
present problems for future work with C-Nterm. The data indicated that base pair #170 in
C-Nterm was a cytosine while the base reported in Pfs230 was an adenine. Base pairs
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#329 and #392 were guanines on the chromatogram while the bases were reported as
adenines in Pfs230.

These base pair substitutions, if they were accurate, would have

changed the primary amino acid structure of Pfs230.C-Nterm. First, amino acid 57 would
be a serine instead of the reported leucine. Peptide sequence indicated that this amino acid
was in fact a leucine.

This raises the possibility about the validity of the base pair

substitution reported in the automated sequencing.

The two remaining base pair

substitutions, assuming they were correct, would have caused amino acid 110 to be a
glutamine instead of the reported glycine and amino acid 131 would be glycine and not the
reported aspartate. Because the difference of molecular weight between these amino acids
is negligible, it is doubtful that they are responsible for the shift in molecular weight
observed with C-Nterm. The isoelectric charges on the amino acids that may have been
substituted are consistent in glutamine and glycine, but glycine (pl 5.97) and aspartate (pl
2.77) differ substantially. The change in pl of one amino acid would probably not alter
the entire pl of a protein and could probably not cause a shift of up to 10 kDa of the CNterm protein on a denaturing polyacrylamide gel. Also, the running buffer used for the
gel was pH 6.8. This is a higher pH than the pl value of both glycine and aspartate.
When pH is higher than pl these residues are negatively charged and migrate towards the
positive electrode. While aspartate is slightly more negative than glycine this difference
would be negligible with respect to migration pattern assuming the SDS had adequately
bound to C-Nterm.
Since C-Nterm multimers were unlikely because it does not contain cysteines and
because C-Nterm was evaluated on a SDS denaturing gel, and no major sequence
rearrangements existed that could explain the large size of C-Nterm, posttranslational
modification of the protein was considered. The most common modification of secreted
yeast proteins is glycosylation, specifically N-linked to asparagines. C-Nterm lacks the
requisite asn-x-ser sequence so it is unlikely that it was N-link glycosylated but 0-link
glycosylation was still a possibility. A glycoprotein detection kit was used to determine if
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carbohydrate moieties were present on C-Nterm. No staining was seen in the purified
fractions of yeast transfected with C-Nterm/mYEp. Only high molecular weight proteins
(specifically proteins from 98 kDa to 41 kDa) present in crude C-Nterm/mYEp transfected
yeast supernatant and material which flowed through the affinity column were stained
(Figure 16) . C-Nterm migrates from roughly 30 kDa to 16 kDa and no bands below 41
k:Da were stained. It was certain that the transfer of C-Nterm protein was successful
because staining of the nitrocellulose with ponceau S revealed bands in the 30 kDa to 16
k:Da range (data not shown). Taken together, these facts suggested that the detection kit
used was able to identify glycoproteins produced by yeast and that C-Nterm was not
glycosylated.
Other possible posttranslational modifications, notably fatty acylation (i.e.
isoprenylation, palmitoylation, and myristoylation (cotranslational)), sulfation, and
phosphorylation could also lead to a larger protein. Isoprenylation is a type of fatty acid
addition which takes on two forms: a 15 carbon isoprenyl lipid, famesyl; a 20 carbon
lipid, geranylgeranyl (Schafer and Rine, 1992). Both isoprenoids add in thioester linkage
to cysteines at the carboxy terminus of a protein. Consensus sequences for isoprenyl
addition are: CAAX (where X determines which type of prenyl addition occurs); CXC
and CL in which one or both cysteines are geranylgeranylated (Caldwell et al., 1995).
Palmitoylation is another type of fatty acylation which involves the posttranslational
attachment of a 16 carbon chain to the thiol group of any cysteine throughout the body of a
polypeptide (Casey, 1995). Because C-Nterm contains no cysteines isoprenylation and
palmitoylation could not have occured.

Myristoylation, which actually occurs

cotranslationally, involves the addition of a 14 carbon chain to the amino terminal glycine
residue in the consensus sequence Met-Gly-X-X-X-Serffhr, where the Met is cleaved
(Resh, 1994). C-Nterm, with the FLAG peptide as its first 15 amino acids, has an amino
terminal aspartate not glycine and therefore myristoylation could not have occured Fatty
acylation is also an unlikely explanation because it is commonly a modification of cytosolic
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proteins which appears to mediate interactions between proteins and cellular membranes
exposed to the cytosol (Alberts, et al., 1994). C-Nterm, of course, is a secreted protein
isolated from the yeast media with no transmembrane domain. Once a protein is in the
secretory pathway it remains inside the endomembranous system and does not appear in
the cytosol (Stryer et al., 1995).
Sulfation and phosphorylation may be possible contributing factors for the
increased size of C-Nterm.

Sulfate groups are covalently added to tyrosines and/or

carbohydrate residues of secretory proteins in the Golgi complex (Rosa et al., 1985).
Phosphate groups are added to the hydroxyl group of serine, threonine or tyrosine
residues. Gel shift assays have shown three phosphoryl additions can correlate with as
much as a 20 kDa increase in size (Izumi and Maller, 1993). C-Nterm has 13 serines,
seven threonines, and eight tyrosines. It is possible that sulfation and phosphorylation are
modifications that take place in parasite-produced Pfs230. In the 360 kDa form of the
protein and the processed 310 kDa form of the protein it is difficult to detect a 10 kDa size
shift. Both of these forms of the protein migrate as a doublet which could be due to
sequential proteolysis.

However, these doublets may be due to posttranslational

modification by the parasite in the form of 0-linked glycosylation, sulfation, or
phosphorylation.
Due to the uncertainty associated with the size of C-Nterm, the question remains is
this project worth exploring further and how can the results of this project be of future
use? It is clear that the mYEp vector constructed in this project will be useful in future
studies. The vector has already been sent to two other investigators to be used in their
experimental work. The six histidine tag and the Nhe I restriction site as well as the
additional stop codon added provide this vector with unique advantages absent in its
unmodified counterpart. Proteins expressed with this vector have the ability of being
purified through the amino terminus (FLAG) and the carboxy terminus (6 his).
Alternatively, a construct could be created using the Kpn I restriction site (outside of the
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MCS) to generate a protein with only a six histidine tag. In addition, the Nhe I site can
serve the dual purpose of distinguishing mYEp from unmodified YEp and can be used for
compatible end ligations to generate future constructs. The additional stop codon serves as
a precaution and is also an asset to mYEp.
With respect to C-Nterm, this project has demonstrated that under the reaction
conditions used, proteins of this size can be efficiently expressed. This is evident by the
amount of protein eluted from the affinity column. Like mYEp, C-Nterm may also play a
role in future studies. C-Nterm has the FLAG peptide at the amino terminus which may
prove useful for amino terminal purification and immunoblot analyses. Furthermore, the
FLAG/C-Nterm fusion protein may also be used to determine if C-Nterm contains the site
where the 360 kDa form of Pfs230 is processed to the 310 kDa form. Conversely, CNterm may be more beneficial without the FLAG because the FLAG peptide is highly
immunogenic and may overpower any immune response generated to recombinant CNterm.
The question as to whether C-Nterm will be useful as an immunogen at all remains
unclear. It is possible that the multiple band pattern associated with C-Nterm represents
posttranslational modifications added by the yeast.

There is a chance that these

modifications might affect conformationally dependent epitopes in the protein. However,
if the multiple band pattern represents posttranslational modifications and these

modifications mimic modifications that actually occur in the parasite, this could be
advantageous.

The nucleotide substitutions which occured in C-Nterm according to

automated sequencing, however, need to be seriously considered. While there was no
indication that these substitutions caused a shift in the reading frame, it is possible that
they may interfere with antibody recognition if the substitutions occured at crucial
epitopes.
Because C-Nterm was designed to be an immunogen, future projects in the lab
with the protein would probably first involve mice immunizations. If it is determined that
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C-Nterm solicits an immune response with a good IgG titer, studies to resolve the size
issue will then be conducted. These experiments might include: 1) Detecting sulfation or
phosphorylation in C-Nterm by labeling the recombinant with
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S sulfate or
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P

orthophosphoric acid, respectively; 2) Running C-Nterm on a tricine gel to determine if
SDS-PAGE anomalies are contributing to the various sizes associated with C-Nterm; 3)
Isoelectric focusing - if different pl' s are associated with different bands this may make
more of a case for phosphorylation or sulfation because these modifications would alter
the pl; 4) Creating a C-Nterm/mYEp construct without the FLAG peptide which may be a
better candidate for immunizing.

CHAPTER V
CONCLUSION

In conclusion, Western blot analysis and sequencing results indicated that Pfs230

amino acid 447 to amino acid 584 (C-Nterm) was expressed as a secreted protein in S.
cerevisiae. The protein was targeted to the yeast secretory pathway via the a signal

sequence encoded by the mYEp vector. The leader sequence was properly removed in the
yeast leaving the FLAG peptide at the amino terminus of C-Nterm. This was determined
because Anti-FLAG Ml, which is specific for FLAG on the exposed amino terminus of a
protein, recognized recombinant C-Nterm. The yeast secreted protein was further shown
to contain amino acids from region C of Pfs230 by immunoblot analysis with Antir230.MBP.C and amino acid sequencing. The recombinant protein was also determined
to have the six histidine sequence at its carboxy terminus due to the fact that it was purified
using a Ni2+-NTA affinity column. This, coupled with the Anti-r230.MBP.C and AntiFLAG Ml reactivity, suggested that full length yeast produced Pfs230.C-Nterm was in
hand.
The primary DNA sequence of C-Nterm/mYEp was shown to be full length and in
the proper reading frame by DNA sequencing. Protein sequencing of recombinant CNterm generated two peptides with perfect sequence homology to amino acid 8 to amino
acid 17 and amino acid 42 to amino acid 58 of the reported sequence of Pfs230.C-Nterm.
Automated sequencing of yC-Nterm/mYEp showed three base pair substitutions when
sequenced from both the 5' and the 3' direction, one of which was corrected in protein
sequencing.
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Secreted C-Nterm migrates on SDS-PAGE as a number of distinct bands. The
precise reason for this remains unclear.

All of the bands appear to be full length.

containing both the amino terminal FLAG sequence and the six histidine tag. There .is no
evidence for a rearranged internal DNA sequence. While the protein does not appear to be
glycosylated, phosphorylation may be a possible explanation as to why C-Nterm migrates
as so many bands.

It is difficult to find a pattern among the bands on every gel.

However, many gels seem to show a one to three kDa increase in size between the bands.
It is possible that each of these bands represents a different degree of modification and that

the lowest molecular weight band (which seems to migrate between 15 kDa-16 kDa
depending on the gel) represents the unmodified C-Nterm protein. Currently, little is
known about specific modifications of parasite-produced Pfs230, but it is possible that
Pfs230 is posttranslationally modified by the parasite.
Possible immediate uses of C-Nterm include testing its immunogenicity in mice
and determining whether the antibodies generated will recognize parasite-produced
Pfs230. If antisera generated to C-Nterm recognizes parasites by immunofluoresence
assay, it would then be tested for its ability to block parasite infectivity in the mosquito.
Because C-Nterm is designed to be used as an immunological reagent and not a chemical
reagent it will first be necessary to determine if decent antibody titer can be generated in
mice. If C-Nterm proves to be immunogenic, the issue of posttranslational modification
as a possible reason for the various sizes will be dealt with further.
Another possibility for C-Nterm is to test this region for its role in stage-specific
processing of Pfs230 from the 360 kDa form to the 310 kDa form. It is predicted that the
clip site for Pfs230 exists within C-Nterm. To test this, recombinant protein could be
incubated in parasite extract then size fractionated to determine if the parasites have
protealyzed the protein to its smaller form. If the size of the protein recognized by AntiFLAG Ml decreases after incubation with the parasite extract this would indicate that
processing of the molecule had occured.
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